date generated: 2022-10-13
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
## x
## 0610009B22Rik -0.23239644
## 0610009E02Rik -1.02165121
## 0610009L18Rik -0.01240851
## 0610010K14Rik -0.07303716
## 0610012G03Rik 0.88341789
## 0610030E20Rik 0.32408607
Here are some metrics about the input data profile:
| Profile metrics | |
|---|---|
| num_genesets | 1604 |
| num_genes_in_profile | 16956 |
| duplicated_genes_present | 0 |
| num_profile_genes_in_sets | 8310 |
| num_profile_genes_not_in_sets | 8646 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
| Gene sets metrics | |
|---|---|
| num_genesets | 1604 |
| num_genesets_excluded | 431 |
| num_genesets_included | 1173 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 2.87e-04 | -0.662 | 0.01510 |
| ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 2.64e-04 | -0.635 | 0.01510 |
| FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 19 | 2.49e-06 | 0.624 | 0.00122 |
| COMMON PATHWAY OF FIBRIN CLOT FORMATION | 10 | 7.10e-04 | 0.618 | 0.02520 |
| INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 12 | 3.32e-04 | 0.598 | 0.01560 |
| BIOTIN TRANSPORT AND METABOLISM | 11 | 1.60e-03 | 0.549 | 0.04080 |
| AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 8.74e-03 | -0.479 | 0.11200 |
| ATTENUATION PHASE | 24 | 8.72e-05 | -0.463 | 0.00731 |
| LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 4.25e-03 | -0.458 | 0.07450 |
| PURINE CATABOLISM | 16 | 1.69e-03 | 0.453 | 0.04160 |
| P38MAPK EVENTS | 12 | 6.81e-03 | -0.451 | 0.09400 |
| TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 2.62e-03 | -0.449 | 0.05430 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 4.39e-03 | -0.440 | 0.07460 |
| ERYTHROPOIETIN ACTIVATES RAS | 13 | 6.39e-03 | -0.437 | 0.08920 |
| REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 2.19e-03 | -0.429 | 0.04840 |
| SIGNALING BY FGFR4 IN DISEASE | 10 | 1.88e-02 | -0.429 | 0.16900 |
| MET ACTIVATES RAP1 AND RAC1 | 11 | 1.39e-02 | -0.428 | 0.14700 |
| MUCOPOLYSACCHARIDOSES | 11 | 1.42e-02 | 0.427 | 0.14800 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 2.00e-02 | -0.405 | 0.17700 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.53e-02 | -0.404 | 0.15500 |
| SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 5.34e-03 | -0.402 | 0.08340 |
| TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 1.21e-02 | -0.402 | 0.13600 |
| HSF1 ACTIVATION | 26 | 5.44e-04 | -0.392 | 0.02270 |
| MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 1.02e-04 | 0.391 | 0.00753 |
| SIGNALING BY ERYTHROPOIETIN | 24 | 1.03e-03 | -0.387 | 0.03170 |
| PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 3.53e-03 | -0.387 | 0.06460 |
| RHOBTB2 GTPASE CYCLE | 23 | 1.37e-03 | -0.386 | 0.03660 |
| MET ACTIVATES RAS SIGNALING | 10 | 3.69e-02 | -0.381 | 0.24400 |
| INTERLEUKIN 27 SIGNALING | 10 | 4.16e-02 | -0.372 | 0.25400 |
| ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 4.30e-02 | -0.370 | 0.25900 |
| CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 1.34e-02 | -0.369 | 0.14300 |
| INTERLEUKIN 35 SIGNALLING | 10 | 4.91e-02 | -0.359 | 0.26400 |
| EPHRIN SIGNALING | 19 | 6.92e-03 | -0.358 | 0.09440 |
| METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 5.24e-02 | 0.354 | 0.27300 |
| NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 5.51e-03 | -0.350 | 0.08340 |
| REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 9.54e-04 | -0.349 | 0.03050 |
| ANTIMICROBIAL PEPTIDES | 15 | 2.19e-02 | 0.342 | 0.18400 |
| IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 6.19e-02 | -0.341 | 0.29800 |
| PLASMA LIPOPROTEIN ASSEMBLY | 11 | 5.17e-02 | 0.339 | 0.27100 |
| GP1B IX V ACTIVATION SIGNALLING | 10 | 6.52e-02 | 0.337 | 0.30700 |
| NUCLEOBASE CATABOLISM | 31 | 1.19e-03 | 0.336 | 0.03390 |
| INSULIN PROCESSING | 24 | 4.39e-03 | -0.336 | 0.07460 |
| SIGNALING BY KIT IN DISEASE | 20 | 9.73e-03 | -0.334 | 0.11600 |
| PLATELET ADHESION TO EXPOSED COLLAGEN | 11 | 5.66e-02 | 0.332 | 0.28500 |
| ASPARTATE AND ASPARAGINE METABOLISM | 11 | 5.68e-02 | 0.332 | 0.28500 |
| GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 4.72e-02 | -0.331 | 0.26400 |
| REGULATION OF IFNA SIGNALING | 12 | 4.85e-02 | -0.329 | 0.26400 |
| VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 1.32e-02 | -0.328 | 0.14300 |
| CD209 DC SIGN SIGNALING | 18 | 1.60e-02 | -0.328 | 0.15800 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 9.75e-03 | 0.326 | 0.11600 |
| set | setSize | pANOVA | s.dist | p.adjustANOVA |
|---|---|---|---|---|
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES | 10 | 2.87e-04 | -0.662000 | 0.01510 |
| ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K | 11 | 2.64e-04 | -0.635000 | 0.01510 |
| FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 19 | 2.49e-06 | 0.624000 | 0.00122 |
| COMMON PATHWAY OF FIBRIN CLOT FORMATION | 10 | 7.10e-04 | 0.618000 | 0.02520 |
| INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION | 12 | 3.32e-04 | 0.598000 | 0.01560 |
| BIOTIN TRANSPORT AND METABOLISM | 11 | 1.60e-03 | 0.549000 | 0.04080 |
| AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS | 10 | 8.74e-03 | -0.479000 | 0.11200 |
| ATTENUATION PHASE | 24 | 8.72e-05 | -0.463000 | 0.00731 |
| LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME | 13 | 4.25e-03 | -0.458000 | 0.07450 |
| PURINE CATABOLISM | 16 | 1.69e-03 | 0.453000 | 0.04160 |
| P38MAPK EVENTS | 12 | 6.81e-03 | -0.451000 | 0.09400 |
| TRAF6 MEDIATED IRF7 ACTIVATION | 15 | 2.62e-03 | -0.449000 | 0.05430 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 14 | 4.39e-03 | -0.440000 | 0.07460 |
| ERYTHROPOIETIN ACTIVATES RAS | 13 | 6.39e-03 | -0.437000 | 0.08920 |
| REGULATION OF RUNX1 EXPRESSION AND ACTIVITY | 17 | 2.19e-03 | -0.429000 | 0.04840 |
| SIGNALING BY FGFR4 IN DISEASE | 10 | 1.88e-02 | -0.429000 | 0.16900 |
| MET ACTIVATES RAP1 AND RAC1 | 11 | 1.39e-02 | -0.428000 | 0.14700 |
| MUCOPOLYSACCHARIDOSES | 11 | 1.42e-02 | 0.427000 | 0.14800 |
| CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE | 11 | 2.00e-02 | -0.405000 | 0.17700 |
| ATF6 ATF6 ALPHA ACTIVATES CHAPERONES | 12 | 1.53e-02 | -0.404000 | 0.15500 |
| SEMA3A PAK DEPENDENT AXON REPULSION | 16 | 5.34e-03 | -0.402000 | 0.08340 |
| TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | 13 | 1.21e-02 | -0.402000 | 0.13600 |
| HSF1 ACTIVATION | 26 | 5.44e-04 | -0.392000 | 0.02270 |
| MITOCHONDRIAL FATTY ACID BETA OXIDATION | 33 | 1.02e-04 | 0.391000 | 0.00753 |
| SIGNALING BY ERYTHROPOIETIN | 24 | 1.03e-03 | -0.387000 | 0.03170 |
| PKA MEDIATED PHOSPHORYLATION OF CREB | 19 | 3.53e-03 | -0.387000 | 0.06460 |
| RHOBTB2 GTPASE CYCLE | 23 | 1.37e-03 | -0.386000 | 0.03660 |
| MET ACTIVATES RAS SIGNALING | 10 | 3.69e-02 | -0.381000 | 0.24400 |
| INTERLEUKIN 27 SIGNALING | 10 | 4.16e-02 | -0.372000 | 0.25400 |
| ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS | 10 | 4.30e-02 | -0.370000 | 0.25900 |
| CONSTITUTIVE SIGNALING BY EGFRVIII | 15 | 1.34e-02 | -0.369000 | 0.14300 |
| INTERLEUKIN 35 SIGNALLING | 10 | 4.91e-02 | -0.359000 | 0.26400 |
| EPHRIN SIGNALING | 19 | 6.92e-03 | -0.358000 | 0.09440 |
| METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS | 10 | 5.24e-02 | 0.354000 | 0.27300 |
| NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION | 21 | 5.51e-03 | -0.350000 | 0.08340 |
| REGULATION OF MECP2 EXPRESSION AND ACTIVITY | 30 | 9.54e-04 | -0.349000 | 0.03050 |
| ANTIMICROBIAL PEPTIDES | 15 | 2.19e-02 | 0.342000 | 0.18400 |
| IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 10 | 6.19e-02 | -0.341000 | 0.29800 |
| PLASMA LIPOPROTEIN ASSEMBLY | 11 | 5.17e-02 | 0.339000 | 0.27100 |
| GP1B IX V ACTIVATION SIGNALLING | 10 | 6.52e-02 | 0.337000 | 0.30700 |
| NUCLEOBASE CATABOLISM | 31 | 1.19e-03 | 0.336000 | 0.03390 |
| INSULIN PROCESSING | 24 | 4.39e-03 | -0.336000 | 0.07460 |
| SIGNALING BY KIT IN DISEASE | 20 | 9.73e-03 | -0.334000 | 0.11600 |
| PLATELET ADHESION TO EXPOSED COLLAGEN | 11 | 5.66e-02 | 0.332000 | 0.28500 |
| ASPARTATE AND ASPARAGINE METABOLISM | 11 | 5.68e-02 | 0.332000 | 0.28500 |
| GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 4.72e-02 | -0.331000 | 0.26400 |
| REGULATION OF IFNA SIGNALING | 12 | 4.85e-02 | -0.329000 | 0.26400 |
| VEGFR2 MEDIATED CELL PROLIFERATION | 19 | 1.32e-02 | -0.328000 | 0.14300 |
| CD209 DC SIGN SIGNALING | 18 | 1.60e-02 | -0.328000 | 0.15800 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 21 | 9.75e-03 | 0.326000 | 0.11600 |
| COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING | 35 | 8.70e-04 | -0.325000 | 0.02920 |
| HSF1 DEPENDENT TRANSACTIVATION | 34 | 1.21e-03 | -0.321000 | 0.03390 |
| REGULATION OF SIGNALING BY CBL | 22 | 9.81e-03 | -0.318000 | 0.11600 |
| CHEMOKINE RECEPTORS BIND CHEMOKINES | 13 | 4.76e-02 | -0.317000 | 0.26400 |
| LYSINE CATABOLISM | 11 | 7.11e-02 | 0.314000 | 0.31800 |
| ACTIVATION OF GENE EXPRESSION BY SREBF SREBP | 43 | 3.84e-04 | -0.313000 | 0.01670 |
| SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL | 13 | 5.14e-02 | 0.312000 | 0.27000 |
| GAP JUNCTION ASSEMBLY | 20 | 1.61e-02 | 0.311000 | 0.15800 |
| PROCESSING OF SMDT1 | 16 | 3.29e-02 | 0.308000 | 0.22700 |
| THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION | 14 | 4.63e-02 | 0.308000 | 0.26400 |
| GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 23 | 1.08e-02 | -0.307000 | 0.12600 |
| RAF INDEPENDENT MAPK1 3 ACTIVATION | 20 | 1.78e-02 | -0.306000 | 0.16400 |
| SIGNALING BY ERBB2 ECD MUTANTS | 16 | 3.45e-02 | -0.305000 | 0.23400 |
| CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY | 13 | 5.86e-02 | -0.303000 | 0.29100 |
| REGULATION OF BACH1 ACTIVITY | 11 | 8.28e-02 | 0.302000 | 0.33700 |
| PYRIMIDINE CATABOLISM | 10 | 9.82e-02 | 0.302000 | 0.35800 |
| FCERI MEDIATED MAPK ACTIVATION | 28 | 6.04e-03 | -0.300000 | 0.08850 |
| INTERFERON ALPHA BETA SIGNALING | 53 | 1.66e-04 | -0.299000 | 0.01150 |
| GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | 16 | 3.92e-02 | -0.298000 | 0.24900 |
| DERMATAN SULFATE BIOSYNTHESIS | 11 | 8.77e-02 | 0.297000 | 0.34100 |
| APOPTOSIS INDUCED DNA FRAGMENTATION | 11 | 8.86e-02 | 0.297000 | 0.34100 |
| NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 10 | 1.05e-01 | -0.296000 | 0.36700 |
| EPHB MEDIATED FORWARD SIGNALING | 42 | 9.64e-04 | -0.294000 | 0.03050 |
| SIGNALING BY FGFR3 FUSIONS IN CANCER | 10 | 1.07e-01 | -0.294000 | 0.36700 |
| SIGNALLING TO RAS | 18 | 3.18e-02 | -0.292000 | 0.22400 |
| RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN | 37 | 2.15e-03 | -0.292000 | 0.04840 |
| ONCOGENIC MAPK SIGNALING | 76 | 1.17e-05 | -0.291000 | 0.00216 |
| STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES | 14 | 6.01e-02 | -0.290000 | 0.29600 |
| LONG TERM POTENTIATION | 23 | 1.63e-02 | -0.290000 | 0.15800 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2 | 13 | 7.10e-02 | 0.289000 | 0.31800 |
| RHOBTB GTPASE CYCLE | 35 | 3.27e-03 | -0.287000 | 0.06190 |
| CALNEXIN CALRETICULIN CYCLE | 26 | 1.14e-02 | -0.287000 | 0.13000 |
| RORA ACTIVATES GENE EXPRESSION | 18 | 3.55e-02 | -0.286000 | 0.23900 |
| CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2 | 11 | 1.02e-01 | -0.285000 | 0.36500 |
| ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM | 12 | 8.85e-02 | 0.284000 | 0.34100 |
| MET RECEPTOR RECYCLING | 10 | 1.20e-01 | -0.284000 | 0.39200 |
| NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 12 | 9.00e-02 | 0.283000 | 0.34300 |
| PKMTS METHYLATE HISTONE LYSINES | 49 | 6.35e-04 | -0.282000 | 0.02400 |
| TIGHT JUNCTION INTERACTIONS | 18 | 3.83e-02 | 0.282000 | 0.24900 |
| CRMPS IN SEMA3A SIGNALING | 16 | 5.14e-02 | -0.281000 | 0.27000 |
| NEUREXINS AND NEUROLIGINS | 54 | 3.75e-04 | -0.280000 | 0.01670 |
| RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES | 20 | 3.08e-02 | -0.279000 | 0.22000 |
| UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION | 21 | 2.74e-02 | -0.278000 | 0.20800 |
| GLUTATHIONE CONJUGATION | 29 | 9.57e-03 | 0.278000 | 0.11600 |
| RNA POLYMERASE III CHAIN ELONGATION | 18 | 4.13e-02 | 0.278000 | 0.25400 |
| SUMOYLATION OF DNA METHYLATION PROTEINS | 16 | 5.50e-02 | -0.277000 | 0.28000 |
| KERATAN SULFATE DEGRADATION | 11 | 1.16e-01 | 0.274000 | 0.38500 |
| DSCAM INTERACTIONS | 10 | 1.35e-01 | -0.273000 | 0.41800 |
| METHYLATION | 12 | 1.02e-01 | 0.272000 | 0.36600 |
| IRE1ALPHA ACTIVATES CHAPERONES | 49 | 1.08e-03 | -0.270000 | 0.03180 |
| CA DEPENDENT EVENTS | 36 | 5.17e-03 | -0.269000 | 0.08340 |
| OVARIAN TUMOR DOMAIN PROTEASES | 36 | 5.20e-03 | -0.269000 | 0.08340 |
| TRANSLESION SYNTHESIS BY POLK | 17 | 5.53e-02 | 0.269000 | 0.28100 |
| DISSOLUTION OF FIBRIN CLOT | 10 | 1.46e-01 | 0.266000 | 0.43100 |
| DAG AND IP3 SIGNALING | 40 | 3.76e-03 | -0.265000 | 0.06780 |
| P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 12 | 1.13e-01 | -0.264000 | 0.38000 |
| INTERLEUKIN 6 SIGNALING | 10 | 1.49e-01 | -0.264000 | 0.43200 |
| ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING | 20 | 4.20e-02 | -0.263000 | 0.25500 |
| TYPE I HEMIDESMOSOME ASSEMBLY | 10 | 1.51e-01 | -0.262000 | 0.43300 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 10 | 1.52e-01 | -0.262000 | 0.43400 |
| PEROXISOMAL LIPID METABOLISM | 26 | 2.10e-02 | 0.262000 | 0.18400 |
| GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION | 25 | 2.39e-02 | 0.261000 | 0.19700 |
| TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS | 54 | 1.07e-03 | -0.257000 | 0.03180 |
| HEME SIGNALING | 45 | 2.83e-03 | -0.257000 | 0.05640 |
| RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR | 20 | 4.65e-02 | -0.257000 | 0.26400 |
| SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS | 12 | 1.24e-01 | -0.257000 | 0.40200 |
| CAMK IV MEDIATED PHOSPHORYLATION OF CREB | 10 | 1.61e-01 | -0.256000 | 0.44400 |
| NS1 MEDIATED EFFECTS ON HOST PATHWAYS | 37 | 7.08e-03 | -0.256000 | 0.09550 |
| PKA ACTIVATION IN GLUCAGON SIGNALLING | 16 | 7.66e-02 | -0.256000 | 0.32700 |
| GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | 19 | 5.40e-02 | 0.255000 | 0.27800 |
| COHESIN LOADING ONTO CHROMATIN | 10 | 1.63e-01 | -0.255000 | 0.44400 |
| ACTIVATION OF SMO | 16 | 7.84e-02 | -0.254000 | 0.33000 |
| MITOCHONDRIAL TRANSLATION | 93 | 2.29e-05 | 0.254000 | 0.00244 |
| THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 22 | 4.10e-02 | -0.252000 | 0.25400 |
| SIGNAL AMPLIFICATION | 30 | 1.80e-02 | -0.250000 | 0.16400 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 23 | 3.93e-02 | -0.248000 | 0.24900 |
| MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS | 18 | 7.02e-02 | -0.246000 | 0.31800 |
| PHASE II CONJUGATION OF COMPOUNDS | 62 | 7.98e-04 | 0.246000 | 0.02750 |
| SIGNALING BY PDGFR IN DISEASE | 20 | 5.69e-02 | -0.246000 | 0.28500 |
| RUNX2 REGULATES BONE DEVELOPMENT | 29 | 2.20e-02 | -0.246000 | 0.18400 |
| VXPX CARGO TARGETING TO CILIUM | 19 | 6.51e-02 | -0.244000 | 0.30700 |
| INTERACTION BETWEEN L1 AND ANKYRINS | 27 | 2.82e-02 | -0.244000 | 0.21100 |
| TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS | 17 | 8.17e-02 | -0.244000 | 0.33600 |
| DAP12 INTERACTIONS | 28 | 2.55e-02 | -0.244000 | 0.20500 |
| FERTILIZATION | 10 | 1.82e-01 | -0.244000 | 0.47200 |
| INTERLEUKIN 10 SIGNALING | 20 | 6.06e-02 | -0.242000 | 0.29600 |
| REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION | 10 | 1.85e-01 | -0.242000 | 0.47300 |
| CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS | 19 | 6.79e-02 | -0.242000 | 0.31400 |
| UNWINDING OF DNA | 12 | 1.48e-01 | 0.241000 | 0.43100 |
| VEGFR2 MEDIATED VASCULAR PERMEABILITY | 27 | 3.01e-02 | -0.241000 | 0.21600 |
| ANCHORING FIBRIL FORMATION | 15 | 1.07e-01 | -0.241000 | 0.36700 |
| PENTOSE PHOSPHATE PATHWAY | 13 | 1.33e-01 | 0.241000 | 0.41800 |
| SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS | 41 | 7.84e-03 | -0.240000 | 0.10200 |
| GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | 31 | 2.12e-02 | 0.239000 | 0.18400 |
| SIGNALING BY RETINOIC ACID | 33 | 1.75e-02 | 0.239000 | 0.16300 |
| MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 31 | 2.14e-02 | -0.239000 | 0.18400 |
| SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS | 11 | 1.71e-01 | -0.238000 | 0.46200 |
| BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION | 26 | 3.58e-02 | -0.238000 | 0.24000 |
| REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | 15 | 1.11e-01 | 0.238000 | 0.37800 |
| CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING | 28 | 2.97e-02 | -0.237000 | 0.21500 |
| CELLULAR HEXOSE TRANSPORT | 11 | 1.75e-01 | 0.236000 | 0.46500 |
| EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS | 31 | 2.31e-02 | -0.236000 | 0.19200 |
| PROTEIN PROTEIN INTERACTIONS AT SYNAPSES | 85 | 1.82e-04 | -0.235000 | 0.01190 |
| TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE | 13 | 1.43e-01 | 0.235000 | 0.43000 |
| ERKS ARE INACTIVATED | 13 | 1.43e-01 | -0.235000 | 0.43000 |
| TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN | 20 | 7.07e-02 | -0.233000 | 0.31800 |
| PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING | 11 | 1.81e-01 | -0.233000 | 0.47200 |
| ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 9.67e-02 | -0.233000 | 0.35500 |
| SIGNALING BY BRAF AND RAF FUSIONS | 60 | 1.85e-03 | -0.232000 | 0.04330 |
| ERK MAPK TARGETS | 22 | 6.16e-02 | -0.230000 | 0.29800 |
| BIOLOGICAL OXIDATIONS | 123 | 1.06e-05 | 0.230000 | 0.00216 |
| INTERLEUKIN RECEPTOR SHC SIGNALING | 20 | 7.54e-02 | -0.230000 | 0.32500 |
| REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF | 56 | 2.96e-03 | -0.230000 | 0.05790 |
| COMPLEMENT CASCADE | 30 | 2.95e-02 | 0.230000 | 0.21500 |
| DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 23 | 5.73e-02 | -0.229000 | 0.28600 |
| OTHER SEMAPHORIN INTERACTIONS | 19 | 8.44e-02 | -0.229000 | 0.33900 |
| ELASTIC FIBRE FORMATION | 37 | 1.61e-02 | 0.229000 | 0.15800 |
| G PROTEIN ACTIVATION | 22 | 6.44e-02 | -0.228000 | 0.30600 |
| REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | 87 | 2.45e-04 | 0.228000 | 0.01510 |
| UNFOLDED PROTEIN RESPONSE UPR | 85 | 2.91e-04 | -0.227000 | 0.01510 |
| INTERFERON GAMMA SIGNALING | 75 | 6.88e-04 | -0.227000 | 0.02520 |
| PERK REGULATES GENE EXPRESSION | 28 | 3.91e-02 | -0.225000 | 0.24900 |
| ACETYLCHOLINE REGULATES INSULIN SECRETION | 10 | 2.17e-01 | -0.225000 | 0.52000 |
| EARLY PHASE OF HIV LIFE CYCLE | 13 | 1.61e-01 | 0.224000 | 0.44400 |
| ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | 22 | 6.86e-02 | -0.224000 | 0.31400 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER | 28 | 4.00e-02 | 0.224000 | 0.25200 |
| G PROTEIN MEDIATED EVENTS | 52 | 5.26e-03 | -0.224000 | 0.08340 |
| ADENYLATE CYCLASE INHIBITORY PATHWAY | 13 | 1.65e-01 | -0.222000 | 0.44800 |
| REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS | 12 | 1.86e-01 | -0.221000 | 0.47400 |
| N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | 35 | 2.42e-02 | -0.220000 | 0.19700 |
| INTEGRIN SIGNALING | 24 | 6.20e-02 | -0.220000 | 0.29800 |
| RAF ACTIVATION | 34 | 2.65e-02 | -0.220000 | 0.20600 |
| NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING | 34 | 2.65e-02 | -0.220000 | 0.20600 |
| CIRCADIAN CLOCK | 68 | 1.72e-03 | -0.220000 | 0.04160 |
| TRANSCRIPTIONAL REGULATION BY E2F6 | 34 | 2.67e-02 | -0.220000 | 0.20600 |
| REGULATION OF TP53 EXPRESSION AND DEGRADATION | 35 | 2.48e-02 | -0.219000 | 0.20100 |
| MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS | 13 | 1.72e-01 | 0.219000 | 0.46200 |
| SIGNALLING TO ERKS | 32 | 3.25e-02 | -0.218000 | 0.22600 |
| REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS | 13 | 1.74e-01 | -0.218000 | 0.46300 |
| GENERATION OF SECOND MESSENGER MOLECULES | 17 | 1.20e-01 | 0.218000 | 0.39200 |
| ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS | 83 | 6.05e-04 | -0.218000 | 0.02360 |
| ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION | 14 | 1.60e-01 | -0.217000 | 0.44400 |
| CHOLESTEROL BIOSYNTHESIS | 24 | 6.57e-02 | -0.217000 | 0.30700 |
| FCGR3A MEDIATED IL10 SYNTHESIS | 34 | 2.88e-02 | -0.217000 | 0.21300 |
| FATTY ACID METABOLISM | 144 | 7.62e-06 | 0.216000 | 0.00216 |
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 19 | 1.03e-01 | -0.216000 | 0.36600 |
| SIGNALING BY ERBB2 IN CANCER | 24 | 6.74e-02 | -0.216000 | 0.31300 |
| MOLECULES ASSOCIATED WITH ELASTIC FIBRES | 31 | 3.78e-02 | 0.216000 | 0.24800 |
| G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 23 | 7.36e-02 | -0.215000 | 0.32300 |
| RHOBTB1 GTPASE CYCLE | 23 | 7.44e-02 | -0.215000 | 0.32300 |
| DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA | 63 | 3.26e-03 | -0.214000 | 0.06190 |
| SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS | 18 | 1.16e-01 | -0.214000 | 0.38500 |
| FORMATION OF THE CORNIFIED ENVELOPE | 31 | 3.93e-02 | 0.214000 | 0.24900 |
| KERATINIZATION | 31 | 3.93e-02 | 0.214000 | 0.24900 |
| ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS | 26 | 6.00e-02 | -0.213000 | 0.29600 |
| REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA | 13 | 1.85e-01 | -0.212000 | 0.47300 |
| INTERFERON SIGNALING | 163 | 3.11e-06 | -0.212000 | 0.00122 |
| TRANSCRIPTIONAL REGULATION BY MECP2 | 60 | 4.58e-03 | -0.212000 | 0.07680 |
| MTORC1 MEDIATED SIGNALLING | 24 | 7.27e-02 | 0.212000 | 0.32200 |
| NCAM SIGNALING FOR NEURITE OUT GROWTH | 58 | 5.55e-03 | -0.211000 | 0.08340 |
| GAP JUNCTION TRAFFICKING AND REGULATION | 32 | 4.14e-02 | 0.208000 | 0.25400 |
| MEIOTIC RECOMBINATION | 38 | 2.63e-02 | 0.208000 | 0.20600 |
| P75NTR REGULATES AXONOGENESIS | 10 | 2.54e-01 | 0.208000 | 0.55900 |
| SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | 18 | 1.26e-01 | -0.208000 | 0.40700 |
| REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE | 76 | 1.74e-03 | -0.208000 | 0.04160 |
| SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS | 58 | 6.23e-03 | -0.208000 | 0.08920 |
| DAP12 SIGNALING | 24 | 7.85e-02 | -0.207000 | 0.33000 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 12 | 2.15e-01 | 0.207000 | 0.51800 |
| CELLULAR RESPONSE TO HEAT STRESS | 95 | 5.60e-04 | -0.205000 | 0.02270 |
| ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3 | 10 | 2.62e-01 | -0.205000 | 0.57000 |
| RHOV GTPASE CYCLE | 32 | 4.54e-02 | -0.204000 | 0.26400 |
| SIGNALING BY FGFR1 IN DISEASE | 32 | 4.64e-02 | -0.204000 | 0.26400 |
| DETOXIFICATION OF REACTIVE OXYGEN SPECIES | 31 | 5.01e-02 | 0.203000 | 0.26700 |
| CTLA4 INHIBITORY SIGNALING | 20 | 1.16e-01 | -0.203000 | 0.38500 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR1 | 24 | 8.63e-02 | -0.202000 | 0.34100 |
| ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | 74 | 2.64e-03 | -0.202000 | 0.05430 |
| NCAM1 INTERACTIONS | 38 | 3.11e-02 | -0.202000 | 0.22100 |
| FORMATION OF INCISION COMPLEX IN GG NER | 43 | 2.20e-02 | 0.202000 | 0.18400 |
| MITOTIC TELOPHASE CYTOKINESIS | 13 | 2.08e-01 | -0.202000 | 0.51000 |
| INTERLEUKIN 20 FAMILY SIGNALING | 13 | 2.10e-01 | -0.201000 | 0.51400 |
| NEGATIVE REGULATION OF MAPK PATHWAY | 41 | 2.65e-02 | -0.200000 | 0.20600 |
| POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION | 26 | 7.75e-02 | -0.200000 | 0.32800 |
| INTERLEUKIN 2 FAMILY SIGNALING | 33 | 4.79e-02 | -0.199000 | 0.26400 |
| CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER | 26 | 7.90e-02 | -0.199000 | 0.33100 |
| SIGNALING BY FLT3 FUSION PROTEINS | 18 | 1.45e-01 | -0.198000 | 0.43100 |
| CITRIC ACID CYCLE TCA CYCLE | 22 | 1.08e-01 | 0.198000 | 0.36700 |
| SEMAPHORIN INTERACTIONS | 64 | 6.25e-03 | -0.198000 | 0.08920 |
| MATURATION OF NUCLEOPROTEIN | 10 | 2.79e-01 | -0.198000 | 0.58400 |
| SIGNALING BY BMP | 25 | 8.73e-02 | -0.198000 | 0.34100 |
| RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION | 23 | 1.01e-01 | -0.197000 | 0.36400 |
| CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 12 | 2.37e-01 | 0.197000 | 0.53800 |
| SIGNALING BY FGFR1 | 42 | 2.81e-02 | -0.196000 | 0.21100 |
| DOWNSTREAM SIGNAL TRANSDUCTION | 29 | 6.84e-02 | -0.196000 | 0.31400 |
| NOD1 2 SIGNALING PATHWAY | 34 | 4.86e-02 | -0.195000 | 0.26400 |
| ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | 10 | 2.86e-01 | -0.195000 | 0.58700 |
| HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | 10 | 2.86e-01 | -0.195000 | 0.58700 |
| FORMATION OF APOPTOSOME | 10 | 2.88e-01 | -0.194000 | 0.58700 |
| CHONDROITIN SULFATE BIOSYNTHESIS | 19 | 1.43e-01 | 0.194000 | 0.43000 |
| UPTAKE AND ACTIONS OF BACTERIAL TOXINS | 29 | 7.15e-02 | -0.193000 | 0.31800 |
| ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3 | 22 | 1.16e-01 | 0.193000 | 0.38500 |
| NUCLEOTIDE SALVAGE | 21 | 1.27e-01 | 0.192000 | 0.40800 |
| RA BIOSYNTHESIS PATHWAY | 13 | 2.30e-01 | 0.192000 | 0.52900 |
| INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING | 41 | 3.32e-02 | -0.192000 | 0.22800 |
| TRAF6 MEDIATED NF KB ACTIVATION | 21 | 1.28e-01 | -0.192000 | 0.41000 |
| PURINE SALVAGE | 12 | 2.50e-01 | 0.192000 | 0.55300 |
| A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | 26 | 9.18e-02 | 0.191000 | 0.34400 |
| OTHER INTERLEUKIN SIGNALING | 19 | 1.50e-01 | -0.191000 | 0.43300 |
| MITOCHONDRIAL CALCIUM ION TRANSPORT | 23 | 1.13e-01 | 0.191000 | 0.38000 |
| NUCLEAR IMPORT OF REV PROTEIN | 32 | 6.19e-02 | -0.191000 | 0.29800 |
| APC CDC20 MEDIATED DEGRADATION OF NEK2A | 26 | 9.24e-02 | 0.191000 | 0.34500 |
| SUMOYLATION OF UBIQUITINYLATION PROTEINS | 37 | 4.51e-02 | -0.190000 | 0.26400 |
| ACTIVATION OF MATRIX METALLOPROTEINASES | 14 | 2.18e-01 | 0.190000 | 0.52000 |
| SIGNALING BY NTRK3 TRKC | 17 | 1.77e-01 | -0.189000 | 0.46700 |
| ER QUALITY CONTROL COMPARTMENT ERQC | 21 | 1.34e-01 | -0.189000 | 0.41800 |
| EXTRA NUCLEAR ESTROGEN SIGNALING | 65 | 8.76e-03 | -0.188000 | 0.11200 |
| THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | 27 | 9.14e-02 | -0.188000 | 0.34400 |
| SYNTHESIS OF PE | 13 | 2.42e-01 | -0.188000 | 0.54100 |
| SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | 20 | 1.47e-01 | 0.187000 | 0.43100 |
| ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 28 | 8.62e-02 | -0.187000 | 0.34100 |
| NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 59 | 1.28e-02 | -0.187000 | 0.14100 |
| PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | 51 | 2.10e-02 | 0.187000 | 0.18400 |
| MISCELLANEOUS TRANSPORT AND BINDING EVENTS | 20 | 1.48e-01 | -0.187000 | 0.43100 |
| NEUROTOXICITY OF CLOSTRIDIUM TOXINS | 10 | 3.07e-01 | -0.187000 | 0.60300 |
| NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 17 | 1.83e-01 | -0.186000 | 0.47300 |
| PHASE I FUNCTIONALIZATION OF COMPOUNDS | 58 | 1.41e-02 | 0.186000 | 0.14800 |
| DNA DAMAGE RECOGNITION IN GG NER | 38 | 4.72e-02 | 0.186000 | 0.26400 |
| GAP JUNCTION DEGRADATION | 11 | 2.86e-01 | 0.186000 | 0.58700 |
| INITIAL TRIGGERING OF COMPLEMENT | 14 | 2.31e-01 | 0.185000 | 0.52900 |
| NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 11 | 2.89e-01 | 0.185000 | 0.58700 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR2 | 23 | 1.25e-01 | -0.185000 | 0.40500 |
| DNA STRAND ELONGATION | 32 | 7.10e-02 | 0.184000 | 0.31800 |
| HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR | 48 | 2.72e-02 | -0.184000 | 0.20800 |
| GABA B RECEPTOR ACTIVATION | 39 | 4.69e-02 | -0.184000 | 0.26400 |
| CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT | 20 | 1.59e-01 | 0.182000 | 0.44400 |
| PHASE 2 PLATEAU PHASE | 13 | 2.59e-01 | 0.181000 | 0.56600 |
| CD28 CO STIMULATION | 31 | 8.16e-02 | -0.181000 | 0.33600 |
| PLATELET SENSITIZATION BY LDL | 15 | 2.28e-01 | -0.180000 | 0.52800 |
| SIGNALING BY NTRK2 TRKB | 24 | 1.29e-01 | -0.179000 | 0.41100 |
| PI 3K CASCADE FGFR2 | 16 | 2.15e-01 | -0.179000 | 0.51800 |
| MAP2K AND MAPK ACTIVATION | 36 | 6.43e-02 | -0.178000 | 0.30600 |
| SIGNALING BY SCF KIT | 41 | 4.86e-02 | -0.178000 | 0.26400 |
| PROLONGED ERK ACTIVATION EVENTS | 13 | 2.68e-01 | -0.177000 | 0.57800 |
| POLYMERASE SWITCHING | 14 | 2.51e-01 | 0.177000 | 0.55300 |
| NUCLEAR PORE COMPLEX NPC DISASSEMBLY | 31 | 8.85e-02 | -0.177000 | 0.34100 |
| FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES | 16 | 2.21e-01 | -0.177000 | 0.52200 |
| MEIOSIS | 64 | 1.50e-02 | 0.176000 | 0.15300 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 19 | 1.84e-01 | -0.176000 | 0.47300 |
| REGULATION OF KIT SIGNALING | 16 | 2.24e-01 | -0.176000 | 0.52400 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 13 | 2.73e-01 | 0.175000 | 0.58100 |
| DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE | 20 | 1.74e-01 | 0.175000 | 0.46400 |
| FORMATION OF THE EARLY ELONGATION COMPLEX | 33 | 8.13e-02 | 0.175000 | 0.33600 |
| SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX | 13 | 2.76e-01 | 0.175000 | 0.58300 |
| INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS | 35 | 7.43e-02 | -0.174000 | 0.32300 |
| DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS | 18 | 2.00e-01 | 0.174000 | 0.49900 |
| SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL | 10 | 3.41e-01 | 0.174000 | 0.63700 |
| MITOCHONDRIAL PROTEIN IMPORT | 63 | 1.71e-02 | 0.174000 | 0.16300 |
| SMOOTH MUSCLE CONTRACTION | 32 | 8.90e-02 | 0.174000 | 0.34100 |
| NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | 18 | 2.03e-01 | -0.173000 | 0.50200 |
| ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS | 35 | 7.63e-02 | -0.173000 | 0.32700 |
| IRF3 MEDIATED INDUCTION OF TYPE I IFN | 11 | 3.21e-01 | -0.173000 | 0.61800 |
| GLUCAGON SIGNALING IN METABOLIC REGULATION | 29 | 1.07e-01 | -0.173000 | 0.36700 |
| SIALIC ACID METABOLISM | 32 | 9.17e-02 | 0.172000 | 0.34400 |
| SIGNALING BY EGFR IN CANCER | 21 | 1.72e-01 | -0.172000 | 0.46200 |
| APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B | 22 | 1.63e-01 | 0.172000 | 0.44400 |
| INTRAFLAGELLAR TRANSPORT | 50 | 3.63e-02 | 0.171000 | 0.24200 |
| ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 23 | 1.56e-01 | -0.171000 | 0.44000 |
| TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES | 11 | 3.29e-01 | -0.170000 | 0.62800 |
| DISEASES OF CARBOHYDRATE METABOLISM | 29 | 1.14e-01 | 0.170000 | 0.38100 |
| SUMOYLATION OF RNA BINDING PROTEINS | 45 | 4.89e-02 | -0.170000 | 0.26400 |
| MITOCHONDRIAL BIOGENESIS | 92 | 4.95e-03 | -0.170000 | 0.08180 |
| DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | 23 | 1.61e-01 | -0.169000 | 0.44400 |
| ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS | 18 | 2.15e-01 | -0.169000 | 0.51800 |
| SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 18 | 2.16e-01 | -0.169000 | 0.51800 |
| CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN | 35 | 8.56e-02 | 0.168000 | 0.34100 |
| PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR | 21 | 1.83e-01 | 0.168000 | 0.47300 |
| NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS | 10 | 3.59e-01 | 0.167000 | 0.65500 |
| KERATAN SULFATE BIOSYNTHESIS | 25 | 1.47e-01 | 0.167000 | 0.43100 |
| TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA | 34 | 9.11e-02 | -0.167000 | 0.34400 |
| EFFECTS OF PIP2 HYDROLYSIS | 27 | 1.33e-01 | -0.167000 | 0.41800 |
| REGULATION OF TNFR1 SIGNALING | 34 | 9.26e-02 | -0.167000 | 0.34500 |
| GLYCOSAMINOGLYCAN METABOLISM | 115 | 2.03e-03 | 0.167000 | 0.04680 |
| ONCOGENE INDUCED SENESCENCE | 32 | 1.05e-01 | -0.166000 | 0.36700 |
| TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | 32 | 1.07e-01 | 0.165000 | 0.36700 |
| PROTEIN METHYLATION | 17 | 2.40e-01 | 0.164000 | 0.53900 |
| IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | 22 | 1.82e-01 | -0.164000 | 0.47200 |
| G PROTEIN BETA GAMMA SIGNALLING | 30 | 1.20e-01 | -0.164000 | 0.39200 |
| SIGNALING BY VEGF | 102 | 4.19e-03 | -0.164000 | 0.07440 |
| HYALURONAN METABOLISM | 15 | 2.72e-01 | 0.164000 | 0.57900 |
| TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7 | 12 | 3.26e-01 | -0.164000 | 0.62300 |
| SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | 11 | 3.47e-01 | 0.164000 | 0.64300 |
| NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 13 | 3.08e-01 | -0.163000 | 0.60300 |
| GABA RECEPTOR ACTIVATION | 53 | 4.02e-02 | -0.163000 | 0.25200 |
| SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | 52 | 4.23e-02 | -0.163000 | 0.25600 |
| GAB1 SIGNALOSOME | 13 | 3.10e-01 | -0.163000 | 0.60300 |
| HYALURONAN UPTAKE AND DEGRADATION | 11 | 3.51e-01 | 0.163000 | 0.64800 |
| PYRUVATE METABOLISM | 27 | 1.44e-01 | 0.162000 | 0.43100 |
| CHROMATIN MODIFYING ENZYMES | 219 | 3.57e-05 | -0.162000 | 0.00349 |
| NGF STIMULATED TRANSCRIPTION | 37 | 8.80e-02 | -0.162000 | 0.34100 |
| DEFECTS IN VITAMIN AND COFACTOR METABOLISM | 21 | 2.01e-01 | 0.161000 | 0.49900 |
| SIGNALING BY ACTIVIN | 12 | 3.34e-01 | -0.161000 | 0.63100 |
| SIGNALING BY ERBB2 | 48 | 5.36e-02 | -0.161000 | 0.27800 |
| METABOLISM OF NUCLEOTIDES | 92 | 7.68e-03 | 0.161000 | 0.10100 |
| DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM | 39 | 8.23e-02 | 0.161000 | 0.33700 |
| RNA POLYMERASE II TRANSCRIBES SNRNA GENES | 74 | 1.75e-02 | -0.160000 | 0.16300 |
| REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION | 30 | 1.31e-01 | -0.159000 | 0.41300 |
| TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS | 45 | 6.54e-02 | 0.159000 | 0.30700 |
| SIGNALING BY NOTCH1 | 75 | 1.76e-02 | -0.159000 | 0.16300 |
| TRANSLESION SYNTHESIS BY POLH | 19 | 2.31e-01 | 0.159000 | 0.52900 |
| FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES | 15 | 2.89e-01 | -0.158000 | 0.58800 |
| TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS | 14 | 3.06e-01 | -0.158000 | 0.60300 |
| AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 14 | 3.07e-01 | -0.158000 | 0.60300 |
| MATURATION OF SARS COV 2 SPIKE PROTEIN | 29 | 1.42e-01 | -0.158000 | 0.43000 |
| TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | 43 | 7.40e-02 | -0.158000 | 0.32300 |
| PEXOPHAGY | 11 | 3.67e-01 | 0.157000 | 0.65800 |
| SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER | 15 | 2.92e-01 | -0.157000 | 0.58900 |
| IRS MEDIATED SIGNALLING | 38 | 9.48e-02 | -0.157000 | 0.35000 |
| FCERI MEDIATED CA 2 MOBILIZATION | 25 | 1.76e-01 | -0.156000 | 0.46500 |
| OPIOID SIGNALLING | 86 | 1.22e-02 | -0.156000 | 0.13600 |
| NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION | 179 | 3.12e-04 | -0.156000 | 0.01520 |
| ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT | 23 | 1.95e-01 | 0.156000 | 0.49000 |
| TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | 63 | 3.25e-02 | 0.156000 | 0.22600 |
| FANCONI ANEMIA PATHWAY | 36 | 1.06e-01 | 0.156000 | 0.36700 |
| FREE FATTY ACIDS REGULATE INSULIN SECRETION | 10 | 3.95e-01 | -0.155000 | 0.67900 |
| METABOLISM OF AMINO ACIDS AND DERIVATIVES | 316 | 2.39e-06 | 0.155000 | 0.00122 |
| FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF | 15 | 3.01e-01 | 0.154000 | 0.60100 |
| NICOTINAMIDE SALVAGING | 16 | 2.86e-01 | 0.154000 | 0.58700 |
| PI METABOLISM | 80 | 1.74e-02 | -0.154000 | 0.16300 |
| REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 30 | 1.45e-01 | -0.154000 | 0.43100 |
| DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX | 41 | 8.96e-02 | -0.153000 | 0.34200 |
| TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | 11 | 3.79e-01 | 0.153000 | 0.67000 |
| INWARDLY RECTIFYING K CHANNELS | 31 | 1.40e-01 | -0.153000 | 0.43000 |
| TNF SIGNALING | 43 | 8.25e-02 | -0.153000 | 0.33700 |
| RHOQ GTPASE CYCLE | 58 | 4.40e-02 | -0.153000 | 0.26300 |
| CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | 49 | 6.41e-02 | 0.153000 | 0.30600 |
| PHOSPHOLIPASE C MEDIATED CASCADE FGFR2 | 11 | 3.82e-01 | -0.152000 | 0.67300 |
| SUMOYLATION OF SUMOYLATION PROTEINS | 33 | 1.31e-01 | -0.152000 | 0.41300 |
| NOTCH HLH TRANSCRIPTION PATHWAY | 28 | 1.64e-01 | -0.152000 | 0.44600 |
| MAPK FAMILY SIGNALING CASCADES | 282 | 1.29e-05 | -0.151000 | 0.00216 |
| RHO GTPASES ACTIVATE KTN1 | 11 | 3.86e-01 | 0.151000 | 0.67600 |
| INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | 21 | 2.31e-01 | 0.151000 | 0.52900 |
| G BETA GAMMA SIGNALLING THROUGH CDC42 | 18 | 2.68e-01 | -0.151000 | 0.57800 |
| LAGGING STRAND SYNTHESIS | 20 | 2.46e-01 | 0.150000 | 0.54800 |
| ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | 17 | 2.87e-01 | -0.149000 | 0.58700 |
| TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY | 29 | 1.65e-01 | -0.149000 | 0.44800 |
| TIE2 SIGNALING | 17 | 2.89e-01 | -0.149000 | 0.58700 |
| GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER | 84 | 1.89e-02 | 0.148000 | 0.16900 |
| TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES | 37 | 1.19e-01 | 0.148000 | 0.39200 |
| UPTAKE AND FUNCTION OF ANTHRAX TOXINS | 11 | 3.98e-01 | -0.147000 | 0.68000 |
| MEIOTIC SYNAPSIS | 41 | 1.03e-01 | 0.147000 | 0.36600 |
| HIV TRANSCRIPTION ELONGATION | 42 | 9.94e-02 | 0.147000 | 0.35900 |
| CYTOCHROME C MEDIATED APOPTOTIC RESPONSE | 12 | 3.79e-01 | -0.147000 | 0.67000 |
| HEPARAN SULFATE HEPARIN HS GAG METABOLISM | 52 | 6.74e-02 | 0.147000 | 0.31300 |
| KERATAN SULFATE KERATIN METABOLISM | 31 | 1.60e-01 | 0.146000 | 0.44400 |
| SUMOYLATION OF TRANSCRIPTION COFACTORS | 42 | 1.03e-01 | -0.145000 | 0.36600 |
| TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT | 18 | 2.87e-01 | -0.145000 | 0.58700 |
| ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS | 20 | 2.62e-01 | 0.145000 | 0.57000 |
| RHOU GTPASE CYCLE | 33 | 1.50e-01 | -0.145000 | 0.43300 |
| CONDENSATION OF PROPHASE CHROMOSOMES | 28 | 1.85e-01 | 0.145000 | 0.47300 |
| RNA POLYMERASE I PROMOTER ESCAPE | 48 | 8.31e-02 | 0.145000 | 0.33700 |
| GLUTATHIONE SYNTHESIS AND RECYCLING | 11 | 4.07e-01 | 0.144000 | 0.68900 |
| SELENOAMINO ACID METABOLISM | 110 | 9.08e-03 | 0.144000 | 0.11200 |
| NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 48 | 8.44e-02 | -0.144000 | 0.33900 |
| SUMOYLATION OF DNA REPLICATION PROTEINS | 43 | 1.03e-01 | -0.144000 | 0.36600 |
| RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | 25 | 2.14e-01 | 0.144000 | 0.51800 |
| MICRORNA MIRNA BIOGENESIS | 24 | 2.24e-01 | -0.143000 | 0.52400 |
| LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS | 19 | 2.80e-01 | -0.143000 | 0.58400 |
| INOSITOL PHOSPHATE METABOLISM | 47 | 9.04e-02 | 0.143000 | 0.34300 |
| CYTOSOLIC SULFONATION OF SMALL MOLECULES | 15 | 3.39e-01 | 0.143000 | 0.63600 |
| G ALPHA Z SIGNALLING EVENTS | 45 | 9.90e-02 | -0.142000 | 0.35900 |
| INTERLEUKIN 6 FAMILY SIGNALING | 19 | 2.84e-01 | -0.142000 | 0.58700 |
| NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 23 | 2.40e-01 | -0.142000 | 0.53900 |
| CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE | 49 | 8.83e-02 | -0.141000 | 0.34100 |
| ASSEMBLY OF THE HIV VIRION | 16 | 3.32e-01 | -0.140000 | 0.63000 |
| GLUCONEOGENESIS | 27 | 2.08e-01 | 0.140000 | 0.51000 |
| REPRESSION OF WNT TARGET GENES | 14 | 3.65e-01 | 0.140000 | 0.65800 |
| PROTEIN LOCALIZATION | 157 | 2.52e-03 | 0.140000 | 0.05370 |
| DUAL INCISION IN GG NER | 41 | 1.23e-01 | 0.139000 | 0.39800 |
| INACTIVATION OF CSF3 G CSF SIGNALING | 24 | 2.38e-01 | -0.139000 | 0.53900 |
| TRANSLATION | 286 | 5.46e-05 | 0.139000 | 0.00492 |
| SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION | 25 | 2.30e-01 | 0.139000 | 0.52900 |
| DCC MEDIATED ATTRACTIVE SIGNALING | 14 | 3.70e-01 | -0.138000 | 0.66100 |
| VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS | 37 | 1.47e-01 | -0.138000 | 0.43100 |
| DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | 39 | 1.38e-01 | 0.137000 | 0.42500 |
| ACTIVATION OF RAC1 | 13 | 3.94e-01 | -0.137000 | 0.67900 |
| VLDLR INTERNALISATION AND DEGRADATION | 11 | 4.33e-01 | 0.137000 | 0.70700 |
| DNA METHYLATION | 21 | 2.79e-01 | 0.136000 | 0.58400 |
| INTERLEUKIN 17 SIGNALING | 67 | 5.40e-02 | -0.136000 | 0.27800 |
| RNA POLYMERASE III TRANSCRIPTION TERMINATION | 23 | 2.59e-01 | 0.136000 | 0.56600 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE | 19 | 3.06e-01 | 0.136000 | 0.60300 |
| SIGNALING BY TGFB FAMILY MEMBERS | 97 | 2.13e-02 | -0.135000 | 0.18400 |
| COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING | 26 | 2.33e-01 | -0.135000 | 0.53200 |
| EUKARYOTIC TRANSLATION ELONGATION | 87 | 2.96e-02 | 0.135000 | 0.21500 |
| LDL CLEARANCE | 15 | 3.65e-01 | -0.135000 | 0.65800 |
| INTRACELLULAR SIGNALING BY SECOND MESSENGERS | 282 | 1.03e-04 | -0.135000 | 0.00753 |
| SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA | 41 | 1.37e-01 | 0.134000 | 0.42500 |
| BASIGIN INTERACTIONS | 22 | 2.77e-01 | 0.134000 | 0.58300 |
| TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX | 12 | 4.23e-01 | 0.134000 | 0.69900 |
| RAP1 SIGNALLING | 15 | 3.71e-01 | -0.133000 | 0.66100 |
| PROCESSING OF INTRONLESS PRE MRNAS | 19 | 3.14e-01 | -0.133000 | 0.60900 |
| SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS | 15 | 3.71e-01 | -0.133000 | 0.66100 |
| SIGNALING BY TGF BETA RECEPTOR COMPLEX | 72 | 5.05e-02 | -0.133000 | 0.26800 |
| SIGNALING BY NTRKS | 129 | 8.98e-03 | -0.133000 | 0.11200 |
| SUMOYLATION | 163 | 3.38e-03 | -0.133000 | 0.06300 |
| FORMATION OF TC NER PRE INCISION COMPLEX | 53 | 9.44e-02 | 0.133000 | 0.34900 |
| DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS | 362 | 1.48e-05 | -0.133000 | 0.00217 |
| G ALPHA 12 13 SIGNALLING EVENTS | 74 | 4.90e-02 | -0.132000 | 0.26400 |
| DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS | 17 | 3.45e-01 | -0.132000 | 0.64100 |
| NEGATIVE REGULATION OF THE PI3K AKT NETWORK | 93 | 2.76e-02 | -0.132000 | 0.20900 |
| VITAMIN B5 PANTOTHENATE METABOLISM | 14 | 3.92e-01 | 0.132000 | 0.67900 |
| DEGRADATION OF CYSTEINE AND HOMOCYSTEINE | 13 | 4.10e-01 | 0.132000 | 0.69000 |
| TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS | 10 | 4.70e-01 | 0.132000 | 0.73500 |
| PRE NOTCH PROCESSING IN GOLGI | 18 | 3.33e-01 | 0.132000 | 0.63100 |
| RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE | 23 | 2.75e-01 | 0.132000 | 0.58300 |
| CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION | 11 | 4.50e-01 | -0.131000 | 0.72100 |
| NUCLEAR SIGNALING BY ERBB4 | 30 | 2.13e-01 | 0.131000 | 0.51800 |
| ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | 10 | 4.72e-01 | 0.131000 | 0.73600 |
| MYOGENESIS | 24 | 2.67e-01 | -0.131000 | 0.57700 |
| CS DS DEGRADATION | 14 | 3.97e-01 | 0.131000 | 0.67900 |
| IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS | 13 | 4.14e-01 | -0.131000 | 0.69100 |
| BASE EXCISION REPAIR AP SITE FORMATION | 30 | 2.17e-01 | 0.130000 | 0.51900 |
| CLASS B 2 SECRETIN FAMILY RECEPTORS | 70 | 6.05e-02 | 0.130000 | 0.29600 |
| MAPK6 MAPK4 SIGNALING | 83 | 4.12e-02 | -0.130000 | 0.25400 |
| FRS MEDIATED FGFR2 SIGNALING | 18 | 3.43e-01 | -0.129000 | 0.64100 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 17 | 3.58e-01 | 0.129000 | 0.65300 |
| APOPTOTIC EXECUTION PHASE | 46 | 1.32e-01 | 0.128000 | 0.41700 |
| SODIUM CALCIUM EXCHANGERS | 10 | 4.83e-01 | -0.128000 | 0.74200 |
| CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION | 21 | 3.11e-01 | -0.128000 | 0.60300 |
| RIP MEDIATED NFKB ACTIVATION VIA ZBP1 | 15 | 3.93e-01 | -0.127000 | 0.67900 |
| MYD88 INDEPENDENT TLR4 CASCADE | 93 | 3.42e-02 | -0.127000 | 0.23300 |
| SHC1 EVENTS IN ERBB2 SIGNALING | 20 | 3.25e-01 | -0.127000 | 0.62300 |
| REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR | 10 | 4.88e-01 | 0.127000 | 0.74800 |
| ELEVATION OF CYTOSOLIC CA2 LEVELS | 14 | 4.13e-01 | 0.126000 | 0.69100 |
| TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS | 41 | 1.62e-01 | -0.126000 | 0.44400 |
| DISEASES OF DNA REPAIR | 11 | 4.69e-01 | -0.126000 | 0.73500 |
| CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 31 | 2.26e-01 | 0.126000 | 0.52400 |
| BILE ACID AND BILE SALT METABOLISM | 25 | 2.77e-01 | 0.126000 | 0.58300 |
| SHC1 EVENTS IN EGFR SIGNALING | 10 | 4.94e-01 | -0.125000 | 0.75000 |
| NEGATIVE REGULATION OF MET ACTIVITY | 21 | 3.22e-01 | -0.125000 | 0.61800 |
| TNFR1 INDUCED PROAPOPTOTIC SIGNALING | 12 | 4.56e-01 | -0.124000 | 0.72400 |
| SYNAPTIC ADHESION LIKE MOLECULES | 21 | 3.26e-01 | -0.124000 | 0.62300 |
| ARACHIDONIC ACID METABOLISM | 38 | 1.90e-01 | 0.123000 | 0.48200 |
| METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS | 103 | 3.16e-02 | 0.123000 | 0.22300 |
| VISUAL PHOTOTRANSDUCTION | 58 | 1.07e-01 | 0.122000 | 0.36700 |
| LGI ADAM INTERACTIONS | 14 | 4.28e-01 | -0.122000 | 0.70200 |
| TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE | 63 | 9.36e-02 | -0.122000 | 0.34700 |
| GROWTH HORMONE RECEPTOR SIGNALING | 20 | 3.45e-01 | -0.122000 | 0.64100 |
| FOXO MEDIATED TRANSCRIPTION | 57 | 1.12e-01 | -0.122000 | 0.37900 |
| SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER | 59 | 1.06e-01 | -0.122000 | 0.36700 |
| TOLL LIKE RECEPTOR 9 TLR9 CASCADE | 91 | 4.55e-02 | -0.121000 | 0.26400 |
| THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS | 24 | 3.05e-01 | -0.121000 | 0.60300 |
| DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE | 46 | 1.56e-01 | 0.121000 | 0.44000 |
| NUCLEOTIDE EXCISION REPAIR | 110 | 2.89e-02 | 0.121000 | 0.21300 |
| CD28 DEPENDENT VAV1 PATHWAY | 11 | 4.90e-01 | -0.120000 | 0.74800 |
| TRANSMISSION ACROSS CHEMICAL SYNAPSES | 240 | 1.37e-03 | -0.120000 | 0.03660 |
| METABOLISM OF VITAMINS AND COFACTORS | 152 | 1.09e-02 | 0.120000 | 0.12600 |
| AQUAPORIN MEDIATED TRANSPORT | 39 | 1.96e-01 | -0.120000 | 0.49000 |
| EPH EPHRIN SIGNALING | 92 | 4.76e-02 | -0.120000 | 0.26400 |
| NICOTINATE METABOLISM | 25 | 3.02e-01 | 0.119000 | 0.60200 |
| SIGNALING BY EGFR | 46 | 1.62e-01 | -0.119000 | 0.44400 |
| REPRODUCTION | 74 | 7.64e-02 | 0.119000 | 0.32700 |
| BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS | 11 | 4.94e-01 | 0.119000 | 0.75000 |
| RET SIGNALING | 35 | 2.25e-01 | -0.118000 | 0.52400 |
| SHC MEDIATED CASCADE FGFR1 | 14 | 4.44e-01 | -0.118000 | 0.71700 |
| NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | 20 | 3.61e-01 | 0.118000 | 0.65700 |
| SIGNALING BY FLT3 ITD AND TKD MUTANTS | 15 | 4.32e-01 | 0.117000 | 0.70700 |
| CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | 20 | 3.65e-01 | 0.117000 | 0.65800 |
| REGULATION OF TP53 ACTIVITY | 151 | 1.34e-02 | -0.117000 | 0.14300 |
| OXIDATIVE STRESS INDUCED SENESCENCE | 79 | 7.32e-02 | -0.117000 | 0.32300 |
| SYNTHESIS OF PA | 31 | 2.62e-01 | -0.117000 | 0.57000 |
| TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS | 30 | 2.69e-01 | 0.117000 | 0.57800 |
| TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | 79 | 7.51e-02 | -0.116000 | 0.32500 |
| TRNA PROCESSING IN THE NUCLEUS | 56 | 1.34e-01 | -0.116000 | 0.41800 |
| INTEGRATION OF ENERGY METABOLISM | 97 | 4.92e-02 | -0.116000 | 0.26400 |
| TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES | 45 | 1.80e-01 | -0.115000 | 0.47200 |
| INSULIN RECEPTOR SIGNALLING CASCADE | 43 | 1.92e-01 | -0.115000 | 0.48400 |
| NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | 52 | 1.52e-01 | -0.115000 | 0.43400 |
| FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS | 83 | 7.15e-02 | -0.114000 | 0.31800 |
| PROLACTIN RECEPTOR SIGNALING | 11 | 5.12e-01 | 0.114000 | 0.76100 |
| SIGNALING BY PDGF | 56 | 1.40e-01 | -0.114000 | 0.43000 |
| UB SPECIFIC PROCESSING PROTEASES | 168 | 1.12e-02 | -0.114000 | 0.12900 |
| PHOSPHORYLATION OF THE APC C | 18 | 4.06e-01 | 0.113000 | 0.68800 |
| CDC42 GTPASE CYCLE | 152 | 1.62e-02 | -0.113000 | 0.15800 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 13 | 4.82e-01 | 0.113000 | 0.74200 |
| CARNITINE METABOLISM | 14 | 4.66e-01 | 0.113000 | 0.73300 |
| COLLAGEN DEGRADATION | 52 | 1.61e-01 | 0.112000 | 0.44400 |
| INITIATION OF NUCLEAR ENVELOPE NE REFORMATION | 16 | 4.38e-01 | 0.112000 | 0.70900 |
| RHOBTB3 ATPASE CYCLE | 10 | 5.41e-01 | 0.112000 | 0.78400 |
| VIRAL MESSENGER RNA SYNTHESIS | 42 | 2.11e-01 | -0.112000 | 0.51500 |
| SULFUR AMINO ACID METABOLISM | 23 | 3.54e-01 | 0.112000 | 0.65200 |
| METABOLISM OF FAT SOLUBLE VITAMINS | 32 | 2.77e-01 | 0.111000 | 0.58300 |
| SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III | 23 | 3.57e-01 | 0.111000 | 0.65300 |
| THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | 172 | 1.24e-02 | 0.111000 | 0.13700 |
| DISEASES OF METABOLISM | 199 | 7.37e-03 | 0.110000 | 0.09820 |
| FGFR1 MUTANT RECEPTOR ACTIVATION | 25 | 3.40e-01 | -0.110000 | 0.63700 |
| NEURONAL SYSTEM | 368 | 2.97e-04 | -0.110000 | 0.01510 |
| SIGNALING BY FGFR | 72 | 1.07e-01 | -0.110000 | 0.36700 |
| RHOA GTPASE CYCLE | 142 | 2.41e-02 | -0.110000 | 0.19700 |
| SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | 31 | 2.91e-01 | -0.110000 | 0.58900 |
| METABOLISM OF CARBOHYDRATES | 258 | 2.48e-03 | 0.110000 | 0.05370 |
| DEADENYLATION OF MRNA | 25 | 3.44e-01 | -0.109000 | 0.64100 |
| PEROXISOMAL PROTEIN IMPORT | 58 | 1.52e-01 | 0.109000 | 0.43500 |
| PIWI INTERACTING RNA PIRNA BIOGENESIS | 21 | 3.89e-01 | -0.109000 | 0.67900 |
| CD28 DEPENDENT PI3K AKT SIGNALING | 21 | 3.91e-01 | -0.108000 | 0.67900 |
| NUCLEAR ENVELOPE BREAKDOWN | 48 | 1.96e-01 | -0.108000 | 0.49000 |
| CYTOKINE SIGNALING IN IMMUNE SYSTEM | 547 | 1.71e-05 | -0.108000 | 0.00223 |
| BASE EXCISION REPAIR | 58 | 1.56e-01 | 0.108000 | 0.44000 |
| CHAPERONE MEDIATED AUTOPHAGY | 20 | 4.04e-01 | 0.108000 | 0.68800 |
| SIGNALING BY FGFR2 IN DISEASE | 36 | 2.65e-01 | -0.107000 | 0.57400 |
| BBSOME MEDIATED CARGO TARGETING TO CILIUM | 23 | 3.74e-01 | -0.107000 | 0.66500 |
| GENE SILENCING BY RNA | 86 | 8.68e-02 | -0.107000 | 0.34100 |
| METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES | 20 | 4.09e-01 | 0.107000 | 0.69000 |
| PI3K AKT SIGNALING IN CANCER | 87 | 8.56e-02 | -0.107000 | 0.34100 |
| ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | 32 | 2.97e-01 | -0.106000 | 0.59600 |
| TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS | 44 | 2.22e-01 | -0.106000 | 0.52200 |
| INHIBITION OF DNA RECOMBINATION AT TELOMERE | 36 | 2.70e-01 | 0.106000 | 0.57800 |
| TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY | 11 | 5.42e-01 | -0.106000 | 0.78400 |
| HCMV EARLY EVENTS | 81 | 9.91e-02 | -0.106000 | 0.35900 |
| PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS | 19 | 4.25e-01 | -0.106000 | 0.69900 |
| DUAL INCISION IN TC NER | 65 | 1.41e-01 | 0.106000 | 0.43000 |
| FATTY ACYL COA BIOSYNTHESIS | 32 | 3.03e-01 | 0.105000 | 0.60300 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 14 | 4.97e-01 | -0.105000 | 0.75100 |
| REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO | 10 | 5.67e-01 | -0.105000 | 0.79900 |
| SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R | 43 | 2.35e-01 | -0.105000 | 0.53600 |
| ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY | 11 | 5.49e-01 | -0.104000 | 0.78600 |
| EUKARYOTIC TRANSLATION INITIATION | 114 | 5.46e-02 | 0.104000 | 0.28000 |
| TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER | 78 | 1.12e-01 | 0.104000 | 0.38000 |
| CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 11 | 5.50e-01 | -0.104000 | 0.78600 |
| RAC1 GTPASE CYCLE | 176 | 1.79e-02 | -0.104000 | 0.16400 |
| PI 3K CASCADE FGFR1 | 14 | 5.02e-01 | -0.104000 | 0.75300 |
| HS GAG DEGRADATION | 20 | 4.24e-01 | 0.103000 | 0.69900 |
| RHO GTPASES ACTIVATE PKNS | 48 | 2.17e-01 | 0.103000 | 0.51900 |
| PHOSPHOLIPID METABOLISM | 190 | 1.46e-02 | -0.103000 | 0.15100 |
| SIGNALING BY INSULIN RECEPTOR | 62 | 1.63e-01 | -0.103000 | 0.44400 |
| DEUBIQUITINATION | 242 | 6.34e-03 | -0.102000 | 0.08920 |
| SIGNALING BY NODAL | 17 | 4.67e-01 | -0.102000 | 0.73300 |
| COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM | 14 | 5.11e-01 | -0.101000 | 0.76100 |
| TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 17 | 4.70e-01 | -0.101000 | 0.73500 |
| REGULATION OF INSULIN SECRETION | 71 | 1.41e-01 | -0.101000 | 0.43000 |
| PARASITE INFECTION | 56 | 1.91e-01 | -0.101000 | 0.48300 |
| NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 12 | 5.46e-01 | 0.101000 | 0.78400 |
| INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | 34 | 3.10e-01 | -0.101000 | 0.60300 |
| ESR MEDIATED SIGNALING | 164 | 2.63e-02 | -0.101000 | 0.20600 |
| VOLTAGE GATED POTASSIUM CHANNELS | 40 | 2.71e-01 | -0.101000 | 0.57900 |
| PEPTIDE LIGAND BINDING RECEPTORS | 91 | 9.78e-02 | 0.100000 | 0.35800 |
| ACYL CHAIN REMODELLING OF PC | 18 | 4.62e-01 | -0.100000 | 0.73200 |
| IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX | 10 | 5.85e-01 | 0.099800 | 0.81400 |
| NRAGE SIGNALS DEATH THROUGH JNK | 55 | 2.01e-01 | -0.099700 | 0.49900 |
| MRNA SPLICING MINOR PATHWAY | 52 | 2.14e-01 | 0.099700 | 0.51800 |
| TRANSCRIPTIONAL REGULATION BY RUNX2 | 110 | 7.12e-02 | -0.099700 | 0.31800 |
| DISEASES OF PROGRAMMED CELL DEATH | 55 | 2.02e-01 | 0.099600 | 0.49900 |
| INSULIN RECEPTOR RECYCLING | 20 | 4.42e-01 | -0.099200 | 0.71600 |
| HEDGEHOG ON STATE | 82 | 1.23e-01 | -0.098700 | 0.39800 |
| PTEN REGULATION | 135 | 4.84e-02 | -0.098500 | 0.26400 |
| SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP | 65 | 1.73e-01 | 0.097800 | 0.46300 |
| DEGRADATION OF THE EXTRACELLULAR MATRIX | 106 | 8.43e-02 | 0.097100 | 0.33900 |
| BETA CATENIN PHOSPHORYLATION CASCADE | 16 | 5.02e-01 | -0.096900 | 0.75300 |
| PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | 16 | 5.05e-01 | -0.096300 | 0.75500 |
| RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX | 30 | 3.62e-01 | 0.096100 | 0.65800 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS | 22 | 4.36e-01 | 0.096000 | 0.70800 |
| RNA POLYMERASE I TRANSCRIPTION TERMINATION | 31 | 3.56e-01 | 0.095900 | 0.65200 |
| PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES | 14 | 5.35e-01 | -0.095800 | 0.78100 |
| PROCESSING AND ACTIVATION OF SUMO | 10 | 6.00e-01 | 0.095800 | 0.82500 |
| APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 34 | 3.34e-01 | 0.095700 | 0.63100 |
| GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION | 38 | 3.08e-01 | -0.095600 | 0.60300 |
| SIGNALING BY CSF3 G CSF | 29 | 3.74e-01 | -0.095400 | 0.66500 |
| REGULATION OF FZD BY UBIQUITINATION | 19 | 4.73e-01 | 0.095100 | 0.73600 |
| TRAFFICKING OF AMPA RECEPTORS | 31 | 3.61e-01 | -0.094900 | 0.65700 |
| FLT3 SIGNALING IN DISEASE | 27 | 3.94e-01 | -0.094800 | 0.67900 |
| SIGNAL TRANSDUCTION BY L1 | 21 | 4.53e-01 | -0.094700 | 0.72100 |
| RUNX3 REGULATES NOTCH SIGNALING | 13 | 5.55e-01 | 0.094400 | 0.79300 |
| DOWNREGULATION OF ERBB2 SIGNALING | 27 | 3.96e-01 | -0.094400 | 0.67900 |
| METABOLISM OF FOLATE AND PTERINES | 15 | 5.31e-01 | 0.093400 | 0.77800 |
| DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | 13 | 5.62e-01 | -0.093000 | 0.79900 |
| ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 38 | 3.22e-01 | -0.092900 | 0.61800 |
| POLO LIKE KINASE MEDIATED EVENTS | 13 | 5.63e-01 | -0.092700 | 0.79900 |
| GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER | 25 | 4.24e-01 | 0.092500 | 0.69900 |
| ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION | 26 | 4.15e-01 | -0.092400 | 0.69100 |
| STRIATED MUSCLE CONTRACTION | 26 | 4.16e-01 | -0.092300 | 0.69100 |
| SIGNALING BY NOTCH3 | 48 | 2.69e-01 | -0.092200 | 0.57800 |
| PLASMA LIPOPROTEIN REMODELING | 15 | 5.37e-01 | 0.092100 | 0.78200 |
| NONSENSE MEDIATED DECAY NMD | 109 | 9.73e-02 | 0.092000 | 0.35700 |
| DISEASES OF GLYCOSYLATION | 124 | 7.71e-02 | 0.092000 | 0.32800 |
| SUMOYLATION OF IMMUNE RESPONSE PROTEINS | 11 | 5.97e-01 | 0.092000 | 0.82500 |
| RRNA PROCESSING IN THE MITOCHONDRION | 10 | 6.15e-01 | 0.091800 | 0.82700 |
| TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 43 | 3.02e-01 | 0.091100 | 0.60100 |
| CGMP EFFECTS | 15 | 5.43e-01 | -0.090800 | 0.78400 |
| HDMS DEMETHYLATE HISTONES | 28 | 4.06e-01 | -0.090800 | 0.68800 |
| CA2 PATHWAY | 56 | 2.40e-01 | -0.090800 | 0.53900 |
| RHO GTPASES ACTIVATE WASPS AND WAVES | 36 | 3.47e-01 | -0.090700 | 0.64200 |
| NETRIN 1 SIGNALING | 48 | 2.81e-01 | -0.090000 | 0.58400 |
| MRNA CAPPING | 29 | 4.03e-01 | 0.089800 | 0.68700 |
| RNA POLYMERASE II TRANSCRIPTION TERMINATION | 65 | 2.12e-01 | -0.089500 | 0.51700 |
| SIGNALING BY THE B CELL RECEPTOR BCR | 103 | 1.17e-01 | -0.089500 | 0.38500 |
| SIGNALING BY FGFR IN DISEASE | 55 | 2.51e-01 | -0.089500 | 0.55300 |
| NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | 21 | 4.79e-01 | -0.089300 | 0.74200 |
| SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS | 73 | 1.88e-01 | -0.089100 | 0.47700 |
| REGULATION OF TP53 ACTIVITY THROUGH METHYLATION | 18 | 5.13e-01 | -0.089000 | 0.76100 |
| TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX | 11 | 6.11e-01 | 0.088600 | 0.82500 |
| DEATH RECEPTOR SIGNALLING | 133 | 8.12e-02 | -0.087700 | 0.33600 |
| REGULATION OF IFNG SIGNALING | 13 | 5.84e-01 | -0.087600 | 0.81400 |
| KILLING MECHANISMS | 10 | 6.32e-01 | -0.087600 | 0.83400 |
| RESOLUTION OF ABASIC SITES AP SITES | 38 | 3.56e-01 | 0.086600 | 0.65200 |
| TRANSCRIPTIONAL REGULATION BY RUNX1 | 179 | 4.62e-02 | -0.086500 | 0.26400 |
| RHOB GTPASE CYCLE | 67 | 2.21e-01 | -0.086400 | 0.52200 |
| YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | 12 | 6.04e-01 | -0.086400 | 0.82500 |
| PI3K EVENTS IN ERBB2 SIGNALING | 14 | 5.78e-01 | -0.085900 | 0.80900 |
| SYNDECAN INTERACTIONS | 26 | 4.50e-01 | 0.085600 | 0.72100 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR4 | 18 | 5.32e-01 | -0.085100 | 0.77800 |
| SUMOYLATION OF TRANSCRIPTION FACTORS | 17 | 5.44e-01 | -0.085100 | 0.78400 |
| PECAM1 INTERACTIONS | 12 | 6.10e-01 | -0.085000 | 0.82500 |
| FC EPSILON RECEPTOR FCERI SIGNALING | 122 | 1.06e-01 | -0.084900 | 0.36700 |
| REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION | 87 | 1.74e-01 | -0.084400 | 0.46300 |
| REGULATION OF GENE EXPRESSION IN BETA CELLS | 10 | 6.44e-01 | -0.084300 | 0.83800 |
| METABOLISM OF STEROID HORMONES | 20 | 5.14e-01 | 0.084300 | 0.76100 |
| INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE | 22 | 4.95e-01 | 0.084000 | 0.75000 |
| REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM | 10 | 6.46e-01 | -0.083800 | 0.83800 |
| SIGNALING BY HEDGEHOG | 141 | 8.65e-02 | -0.083700 | 0.34100 |
| NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10 | 11 | 6.32e-01 | -0.083300 | 0.83400 |
| GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION | 31 | 4.24e-01 | 0.083100 | 0.69900 |
| FLT3 SIGNALING | 37 | 3.84e-01 | -0.082800 | 0.67500 |
| RECEPTOR MEDIATED MITOPHAGY | 11 | 6.35e-01 | -0.082700 | 0.83700 |
| NEGATIVE REGULATION OF FGFR2 SIGNALING | 27 | 4.58e-01 | -0.082500 | 0.72600 |
| RESPIRATORY ELECTRON TRANSPORT | 102 | 1.51e-01 | 0.082400 | 0.43300 |
| METABOLISM OF COFACTORS | 18 | 5.45e-01 | 0.082400 | 0.78400 |
| REGULATION OF RAS BY GAPS | 66 | 2.51e-01 | -0.081800 | 0.55300 |
| REDUCTION OF CYTOSOLIC CA LEVELS | 12 | 6.25e-01 | -0.081400 | 0.83100 |
| DARPP 32 EVENTS | 23 | 4.99e-01 | -0.081400 | 0.75200 |
| SIGNALING BY RECEPTOR TYROSINE KINASES | 462 | 2.84e-03 | -0.081300 | 0.05640 |
| REGULATION OF TLR BY ENDOGENOUS LIGAND | 12 | 6.26e-01 | 0.081200 | 0.83100 |
| SUMOYLATION OF INTRACELLULAR RECEPTORS | 25 | 4.83e-01 | 0.081200 | 0.74200 |
| RNA POLYMERASE I TRANSCRIPTION | 68 | 2.47e-01 | 0.081200 | 0.55100 |
| TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN | 12 | 6.29e-01 | 0.080600 | 0.83300 |
| TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE | 92 | 1.82e-01 | -0.080500 | 0.47200 |
| SCAVENGING BY CLASS A RECEPTORS | 14 | 6.02e-01 | 0.080500 | 0.82500 |
| HS GAG BIOSYNTHESIS | 30 | 4.46e-01 | 0.080400 | 0.71800 |
| MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 15 | 5.90e-01 | 0.080400 | 0.82000 |
| NERVOUS SYSTEM DEVELOPMENT | 543 | 1.44e-03 | -0.080300 | 0.03750 |
| SIGNALING BY FGFR2 | 62 | 2.79e-01 | -0.079600 | 0.58400 |
| ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | 59 | 2.91e-01 | 0.079400 | 0.58900 |
| L1CAM INTERACTIONS | 107 | 1.57e-01 | -0.079200 | 0.44200 |
| REGULATION OF RUNX2 EXPRESSION AND ACTIVITY | 69 | 2.56e-01 | -0.079200 | 0.56100 |
| NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 41 | 3.82e-01 | -0.078900 | 0.67300 |
| CYCLIN D ASSOCIATED EVENTS IN G1 | 46 | 3.55e-01 | 0.078800 | 0.65200 |
| RHO GTPASE CYCLE | 425 | 5.50e-03 | -0.078700 | 0.08340 |
| RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | 125 | 1.29e-01 | 0.078700 | 0.41100 |
| DNA REPLICATION | 122 | 1.34e-01 | 0.078600 | 0.41800 |
| INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING | 83 | 2.20e-01 | -0.078000 | 0.52100 |
| SIGNALING BY FGFR4 | 32 | 4.46e-01 | -0.077900 | 0.71800 |
| POTENTIAL THERAPEUTICS FOR SARS | 77 | 2.39e-01 | -0.077700 | 0.53900 |
| RNA POLYMERASE II TRANSCRIPTION | 1089 | 1.91e-05 | -0.077300 | 0.00224 |
| FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES | 23 | 5.21e-01 | -0.077300 | 0.76700 |
| PYRIMIDINE SALVAGE | 10 | 6.73e-01 | 0.077000 | 0.85500 |
| ACYL CHAIN REMODELLING OF PG | 11 | 6.59e-01 | -0.076900 | 0.84500 |
| METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION | 15 | 6.07e-01 | 0.076800 | 0.82500 |
| REGULATED PROTEOLYSIS OF P75NTR | 12 | 6.46e-01 | -0.076500 | 0.83800 |
| SIGNALING BY FGFR2 IIIA TM | 19 | 5.65e-01 | 0.076200 | 0.79900 |
| INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL | 15 | 6.09e-01 | -0.076200 | 0.82500 |
| OLFACTORY SIGNALING PATHWAY | 27 | 4.94e-01 | -0.076100 | 0.75000 |
| SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE | 87 | 2.21e-01 | 0.075900 | 0.52200 |
| REGULATION OF PTEN GENE TRANSCRIPTION | 60 | 3.10e-01 | -0.075800 | 0.60300 |
| RESOLUTION OF SISTER CHROMATID COHESION | 103 | 1.86e-01 | -0.075400 | 0.47400 |
| GLYCOSPHINGOLIPID METABOLISM | 39 | 4.15e-01 | 0.075400 | 0.69100 |
| RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY | 95 | 2.06e-01 | 0.075200 | 0.50700 |
| BUDDING AND MATURATION OF HIV VIRION | 27 | 4.99e-01 | 0.075100 | 0.75200 |
| RHO GTPASES ACTIVATE FORMINS | 121 | 1.55e-01 | -0.074900 | 0.44000 |
| RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | 108 | 1.80e-01 | 0.074700 | 0.47200 |
| ION TRANSPORT BY P TYPE ATPASES | 47 | 3.77e-01 | 0.074600 | 0.66800 |
| REGULATION OF PTEN STABILITY AND ACTIVITY | 66 | 2.98e-01 | -0.074100 | 0.59700 |
| ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 23 | 5.39e-01 | -0.074000 | 0.78200 |
| GPCR LIGAND BINDING | 243 | 4.74e-02 | 0.074000 | 0.26400 |
| SIGNALING BY NOTCH | 190 | 7.99e-02 | -0.073800 | 0.33300 |
| RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY | 15 | 6.22e-01 | -0.073500 | 0.83100 |
| TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE | 39 | 4.27e-01 | 0.073500 | 0.70100 |
| DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS | 51 | 3.66e-01 | 0.073200 | 0.65800 |
| RND3 GTPASE CYCLE | 38 | 4.35e-01 | -0.073100 | 0.70800 |
| REGULATION OF HMOX1 EXPRESSION AND ACTIVITY | 63 | 3.18e-01 | 0.072800 | 0.61300 |
| RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS | 84 | 2.49e-01 | 0.072800 | 0.55300 |
| PROTEIN FOLDING | 89 | 2.36e-01 | -0.072700 | 0.53600 |
| PREGNENOLONE BIOSYNTHESIS | 12 | 6.64e-01 | -0.072500 | 0.84800 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST | 13 | 6.52e-01 | -0.072300 | 0.83900 |
| O LINKED GLYCOSYLATION | 87 | 2.46e-01 | 0.072000 | 0.54800 |
| TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | 32 | 4.82e-01 | -0.071900 | 0.74200 |
| LATE ENDOSOMAL MICROAUTOPHAGY | 31 | 4.89e-01 | 0.071800 | 0.74800 |
| APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | 71 | 2.97e-01 | 0.071600 | 0.59600 |
| MTOR SIGNALLING | 40 | 4.34e-01 | 0.071500 | 0.70700 |
| SIGNALING BY WNT | 268 | 4.54e-02 | -0.071100 | 0.26400 |
| SARS COV INFECTIONS | 140 | 1.48e-01 | -0.070900 | 0.43100 |
| GLYCEROPHOSPHOLIPID BIOSYNTHESIS | 111 | 2.01e-01 | -0.070300 | 0.49900 |
| APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS | 83 | 2.71e-01 | 0.070000 | 0.57900 |
| MITOTIC SPINDLE CHECKPOINT | 100 | 2.27e-01 | -0.069900 | 0.52700 |
| CHROMOSOME MAINTENANCE | 103 | 2.21e-01 | 0.069800 | 0.52200 |
| APOPTOTIC FACTOR MEDIATED RESPONSE | 18 | 6.10e-01 | -0.069400 | 0.82500 |
| SIGNALING BY HIPPO | 20 | 5.92e-01 | -0.069200 | 0.82100 |
| POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | 57 | 3.66e-01 | 0.069200 | 0.65800 |
| TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 83 | 2.77e-01 | -0.069000 | 0.58300 |
| SUPPRESSION OF PHAGOSOMAL MATURATION | 13 | 6.67e-01 | -0.068900 | 0.85100 |
| REGULATION OF LIPID METABOLISM BY PPARALPHA | 108 | 2.22e-01 | -0.068100 | 0.52200 |
| SPHINGOLIPID DE NOVO BIOSYNTHESIS | 41 | 4.51e-01 | -0.068000 | 0.72100 |
| COSTIMULATION BY THE CD28 FAMILY | 49 | 4.12e-01 | -0.067800 | 0.69100 |
| DISEASES OF IMMUNE SYSTEM | 24 | 5.66e-01 | -0.067600 | 0.79900 |
| ACTIVATION OF AMPK DOWNSTREAM OF NMDARS | 20 | 6.01e-01 | -0.067600 | 0.82500 |
| HIV ELONGATION ARREST AND RECOVERY | 32 | 5.09e-01 | 0.067500 | 0.75900 |
| REGULATION OF EXPRESSION OF SLITS AND ROBOS | 159 | 1.43e-01 | 0.067400 | 0.43000 |
| SEMA4D IN SEMAPHORIN SIGNALING | 24 | 5.70e-01 | -0.067000 | 0.80100 |
| RMTS METHYLATE HISTONE ARGININES | 44 | 4.43e-01 | -0.066900 | 0.71600 |
| FRS MEDIATED FGFR3 SIGNALING | 15 | 6.54e-01 | 0.066900 | 0.84100 |
| PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE | 49 | 4.24e-01 | 0.066100 | 0.69900 |
| S PHASE | 156 | 1.56e-01 | 0.065900 | 0.44000 |
| O LINKED GLYCOSYLATION OF MUCINS | 41 | 4.67e-01 | 0.065700 | 0.73300 |
| P75 NTR RECEPTOR MEDIATED SIGNALLING | 94 | 2.72e-01 | -0.065500 | 0.58000 |
| LYSOSPHINGOLIPID AND LPA RECEPTORS | 12 | 6.95e-01 | -0.065500 | 0.86400 |
| NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 17 | 6.41e-01 | 0.065300 | 0.83700 |
| SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3 | 630 | 5.70e-03 | -0.064800 | 0.08460 |
| ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION | 33 | 5.20e-01 | 0.064800 | 0.76600 |
| SIGNALING BY INTERLEUKINS | 351 | 3.78e-02 | -0.064700 | 0.24800 |
| NEPHRIN FAMILY INTERACTIONS | 22 | 6.00e-01 | -0.064500 | 0.82500 |
| SYNTHESIS OF PC | 26 | 5.69e-01 | -0.064500 | 0.80100 |
| ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 33 | 5.23e-01 | 0.064300 | 0.76800 |
| RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 85 | 3.07e-01 | 0.064100 | 0.60300 |
| CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND | 14 | 6.78e-01 | -0.064100 | 0.85900 |
| METABOLISM OF STEROIDS | 113 | 2.40e-01 | -0.064000 | 0.53900 |
| HATS ACETYLATE HISTONES | 93 | 2.88e-01 | -0.063800 | 0.58700 |
| SIGNALING BY NOTCH4 | 83 | 3.16e-01 | 0.063700 | 0.61100 |
| DEREGULATED CDK5 TRIGGERS MULTIPLE NEURODEGENERATIVE PATHWAYS IN ALZHEIMER S DISEASE MODELS | 19 | 6.37e-01 | 0.062500 | 0.83700 |
| SARS COV 2 INFECTION | 65 | 3.85e-01 | -0.062400 | 0.67600 |
| TRNA AMINOACYLATION | 42 | 4.85e-01 | 0.062200 | 0.74500 |
| O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS | 36 | 5.20e-01 | 0.062000 | 0.76600 |
| RESOLUTION OF D LOOP STRUCTURES | 30 | 5.57e-01 | 0.062000 | 0.79300 |
| TELOMERE C STRAND LAGGING STRAND SYNTHESIS | 33 | 5.38e-01 | 0.061900 | 0.78200 |
| N GLYCAN ANTENNAE ELONGATION | 15 | 6.79e-01 | -0.061800 | 0.85900 |
| G ALPHA I SIGNALLING EVENTS | 190 | 1.43e-01 | -0.061700 | 0.43000 |
| TRANSCRIPTIONAL REGULATION BY VENTX | 36 | 5.23e-01 | -0.061600 | 0.76800 |
| EPH EPHRIN MEDIATED REPULSION OF CELLS | 51 | 4.47e-01 | -0.061500 | 0.71900 |
| RHOJ GTPASE CYCLE | 54 | 4.37e-01 | -0.061200 | 0.70800 |
| SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 60 | 4.13e-01 | 0.061200 | 0.69100 |
| CLASS A 1 RHODOPSIN LIKE RECEPTORS | 162 | 1.80e-01 | 0.061200 | 0.47200 |
| DEFECTIVE EXT2 CAUSES EXOSTOSES 2 | 14 | 6.92e-01 | 0.061100 | 0.86400 |
| HCMV INFECTION | 104 | 2.83e-01 | -0.061000 | 0.58700 |
| RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION | 51 | 4.52e-01 | -0.060900 | 0.72100 |
| SLC TRANSPORTER DISORDERS | 71 | 3.76e-01 | -0.060800 | 0.66700 |
| NUCLEOBASE BIOSYNTHESIS | 15 | 6.84e-01 | 0.060700 | 0.86100 |
| DEFECTS IN COBALAMIN B12 METABOLISM | 13 | 7.05e-01 | -0.060700 | 0.86800 |
| RRNA PROCESSING | 194 | 1.48e-01 | 0.060300 | 0.43100 |
| ASYMMETRIC LOCALIZATION OF PCP PROTEINS | 62 | 4.12e-01 | 0.060200 | 0.69100 |
| ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 29 | 5.75e-01 | 0.060100 | 0.80600 |
| ESTROGEN DEPENDENT GENE EXPRESSION | 103 | 2.92e-01 | -0.060100 | 0.58900 |
| TBC RABGAPS | 43 | 4.96e-01 | -0.060000 | 0.75100 |
| NONHOMOLOGOUS END JOINING NHEJ | 44 | 4.91e-01 | -0.060000 | 0.74800 |
| INTERLEUKIN 7 SIGNALING | 20 | 6.42e-01 | 0.060000 | 0.83700 |
| PLATELET HOMEOSTASIS | 78 | 3.63e-01 | -0.059600 | 0.65800 |
| CELL CELL JUNCTION ORGANIZATION | 51 | 4.63e-01 | 0.059400 | 0.73200 |
| MHC CLASS II ANTIGEN PRESENTATION | 101 | 3.04e-01 | 0.059200 | 0.60300 |
| POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE | 25 | 6.10e-01 | 0.059000 | 0.82500 |
| SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 106 | 2.96e-01 | 0.058800 | 0.59600 |
| METALLOPROTEASE DUBS | 26 | 6.05e-01 | 0.058700 | 0.82500 |
| RHO GTPASES ACTIVATE NADPH OXIDASES | 19 | 6.60e-01 | 0.058400 | 0.84500 |
| TELOMERE EXTENSION BY TELOMERASE | 22 | 6.36e-01 | -0.058300 | 0.83700 |
| CELLULAR RESPONSE TO CHEMICAL STRESS | 150 | 2.19e-01 | 0.058200 | 0.52100 |
| CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 92 | 3.37e-01 | 0.058000 | 0.63400 |
| SIGNALING BY WNT IN CANCER | 30 | 5.83e-01 | 0.058000 | 0.81300 |
| GLYCOGEN SYNTHESIS | 14 | 7.08e-01 | -0.057800 | 0.87000 |
| SLC MEDIATED TRANSMEMBRANE TRANSPORT | 185 | 1.79e-01 | 0.057400 | 0.47100 |
| SNRNP ASSEMBLY | 51 | 4.80e-01 | -0.057200 | 0.74200 |
| POTASSIUM CHANNELS | 90 | 3.51e-01 | -0.056900 | 0.64800 |
| FRS MEDIATED FGFR1 SIGNALING | 16 | 6.95e-01 | -0.056700 | 0.86400 |
| EXTRACELLULAR MATRIX ORGANIZATION | 242 | 1.30e-01 | 0.056600 | 0.41300 |
| FGFR2 ALTERNATIVE SPLICING | 25 | 6.25e-01 | -0.056500 | 0.83100 |
| MISMATCH REPAIR | 14 | 7.18e-01 | 0.055800 | 0.87500 |
| HDACS DEACETYLATE HISTONES | 47 | 5.09e-01 | -0.055700 | 0.75900 |
| CELLULAR RESPONSE TO STARVATION | 146 | 2.49e-01 | 0.055300 | 0.55300 |
| COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES | 63 | 4.48e-01 | -0.055300 | 0.71900 |
| PEPTIDE HORMONE METABOLISM | 57 | 4.71e-01 | -0.055200 | 0.73500 |
| DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | 78 | 4.01e-01 | -0.055100 | 0.68400 |
| TRP CHANNELS | 18 | 6.87e-01 | -0.054900 | 0.86200 |
| LYSOSOME VESICLE BIOGENESIS | 32 | 5.92e-01 | 0.054800 | 0.82100 |
| TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | 77 | 4.06e-01 | -0.054800 | 0.68800 |
| AURKA ACTIVATION BY TPX2 | 71 | 4.28e-01 | 0.054500 | 0.70100 |
| DEVELOPMENTAL BIOLOGY | 814 | 9.01e-03 | -0.054200 | 0.11200 |
| IRON UPTAKE AND TRANSPORT | 52 | 5.00e-01 | 0.054000 | 0.75200 |
| CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER | 60 | 4.71e-01 | -0.053900 | 0.73500 |
| AMINE LIGAND BINDING RECEPTORS | 29 | 6.16e-01 | 0.053800 | 0.82700 |
| REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | 84 | 3.94e-01 | -0.053800 | 0.67900 |
| RHO GTPASES ACTIVATE CIT | 18 | 6.93e-01 | 0.053700 | 0.86400 |
| AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 26 | 6.36e-01 | 0.053600 | 0.83700 |
| NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX | 32 | 6.01e-01 | -0.053500 | 0.82500 |
| GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION | 11 | 7.59e-01 | 0.053300 | 0.90400 |
| ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | 64 | 4.64e-01 | 0.052900 | 0.73200 |
| DISEASES OF MITOTIC CELL CYCLE | 38 | 5.73e-01 | 0.052900 | 0.80300 |
| UCH PROTEINASES | 89 | 3.89e-01 | 0.052800 | 0.67900 |
| HOST INTERACTIONS OF HIV FACTORS | 122 | 3.15e-01 | -0.052700 | 0.61100 |
| KSRP KHSRP BINDS AND DESTABILIZES MRNA | 16 | 7.15e-01 | -0.052700 | 0.87400 |
| RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | 78 | 4.24e-01 | 0.052400 | 0.69900 |
| EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION | 27 | 6.40e-01 | -0.052000 | 0.83700 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX | 18 | 7.03e-01 | 0.051900 | 0.86800 |
| FGFR2 LIGAND BINDING AND ACTIVATION | 11 | 7.66e-01 | -0.051900 | 0.90500 |
| ORC1 REMOVAL FROM CHROMATIN | 67 | 4.64e-01 | 0.051800 | 0.73200 |
| ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | 30 | 6.25e-01 | 0.051600 | 0.83100 |
| NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 26 | 6.50e-01 | -0.051400 | 0.83900 |
| INTERLEUKIN 37 SIGNALING | 18 | 7.06e-01 | -0.051400 | 0.86800 |
| G ALPHA Q SIGNALLING EVENTS | 147 | 2.86e-01 | -0.051000 | 0.58700 |
| TELOMERE MAINTENANCE | 79 | 4.34e-01 | 0.051000 | 0.70700 |
| SIGNALING BY FGFR3 | 35 | 6.02e-01 | -0.050900 | 0.82500 |
| CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY | 85 | 4.19e-01 | 0.050800 | 0.69500 |
| GLYCOLYSIS | 66 | 4.77e-01 | -0.050600 | 0.74100 |
| RHOC GTPASE CYCLE | 73 | 4.56e-01 | -0.050500 | 0.72400 |
| INTERLEUKIN 12 SIGNALING | 37 | 5.97e-01 | 0.050300 | 0.82500 |
| PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE | 19 | 7.05e-01 | 0.050200 | 0.86800 |
| CRISTAE FORMATION | 31 | 6.29e-01 | 0.050100 | 0.83300 |
| COMPLEX I BIOGENESIS | 56 | 5.17e-01 | 0.050000 | 0.76400 |
| DNA REPAIR | 294 | 1.41e-01 | 0.050000 | 0.43000 |
| PROCESSING OF CAPPED INTRONLESS PRE MRNA | 28 | 6.47e-01 | -0.050000 | 0.83800 |
| SIGNALING BY MET | 76 | 4.55e-01 | -0.049600 | 0.72400 |
| PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION | 23 | 6.80e-01 | 0.049600 | 0.85900 |
| MITOCHONDRIAL TRNA AMINOACYLATION | 21 | 6.94e-01 | 0.049500 | 0.86400 |
| ANTIGEN PROCESSING CROSS PRESENTATION | 93 | 4.10e-01 | -0.049500 | 0.69000 |
| PRC2 METHYLATES HISTONES AND DNA | 30 | 6.42e-01 | 0.049100 | 0.83700 |
| ECM PROTEOGLYCANS | 66 | 4.91e-01 | 0.049000 | 0.74800 |
| EPHA MEDIATED GROWTH CONE COLLAPSE | 29 | 6.49e-01 | -0.048800 | 0.83800 |
| EPIGENETIC REGULATION OF GENE EXPRESSION | 104 | 3.95e-01 | -0.048400 | 0.67900 |
| NEGATIVE REGULATION OF NOTCH4 SIGNALING | 54 | 5.39e-01 | 0.048300 | 0.78200 |
| MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION | 16 | 7.38e-01 | 0.048300 | 0.88900 |
| BLOOD GROUP SYSTEMS BIOSYNTHESIS | 12 | 7.73e-01 | 0.048100 | 0.90700 |
| TERMINATION OF TRANSLESION DNA SYNTHESIS | 32 | 6.40e-01 | 0.047800 | 0.83700 |
| MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 15 | 7.49e-01 | -0.047700 | 0.89900 |
| INTERLEUKIN 15 SIGNALING | 13 | 7.66e-01 | 0.047600 | 0.90500 |
| PHASE 4 RESTING MEMBRANE POTENTIAL | 13 | 7.66e-01 | 0.047600 | 0.90500 |
| ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS | 67 | 5.01e-01 | -0.047600 | 0.75300 |
| NEUROTRANSMITTER RELEASE CYCLE | 49 | 5.66e-01 | -0.047400 | 0.79900 |
| TOLL LIKE RECEPTOR CASCADES | 137 | 3.39e-01 | -0.047400 | 0.63600 |
| SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | 12 | 7.78e-01 | -0.047100 | 0.90800 |
| SENSORY PERCEPTION | 144 | 3.30e-01 | 0.047100 | 0.62800 |
| ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA | 15 | 7.53e-01 | 0.047000 | 0.90000 |
| CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 73 | 4.89e-01 | -0.046900 | 0.74800 |
| SIGNALING BY ERBB4 | 56 | 5.45e-01 | -0.046800 | 0.78400 |
| SIGNALING BY PTK6 | 51 | 5.66e-01 | -0.046500 | 0.79900 |
| CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND | 10 | 7.99e-01 | 0.046500 | 0.92000 |
| TRIGLYCERIDE CATABOLISM | 14 | 7.64e-01 | 0.046300 | 0.90500 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR3 | 20 | 7.22e-01 | -0.046000 | 0.87700 |
| METABOLISM OF PORPHYRINS | 19 | 7.29e-01 | 0.045900 | 0.88400 |
| NEGATIVE REGULATION OF FGFR3 SIGNALING | 24 | 6.98e-01 | 0.045800 | 0.86700 |
| SIGNALING BY LEPTIN | 10 | 8.04e-01 | 0.045300 | 0.92300 |
| ORGANELLE BIOGENESIS AND MAINTENANCE | 282 | 1.93e-01 | -0.045200 | 0.48500 |
| MET PROMOTES CELL MOTILITY | 40 | 6.24e-01 | -0.044800 | 0.83100 |
| GLYCOGEN METABOLISM | 25 | 6.99e-01 | -0.044600 | 0.86700 |
| ROS AND RNS PRODUCTION IN PHAGOCYTES | 29 | 6.78e-01 | 0.044500 | 0.85900 |
| RAB REGULATION OF TRAFFICKING | 120 | 4.05e-01 | -0.044100 | 0.68800 |
| TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST | 15 | 7.68e-01 | -0.044000 | 0.90500 |
| TRANSCRIPTION OF THE HIV GENOME | 67 | 5.36e-01 | 0.043700 | 0.78200 |
| PLATELET AGGREGATION PLUG FORMATION | 32 | 6.71e-01 | -0.043500 | 0.85300 |
| CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | 345 | 1.68e-01 | -0.043300 | 0.45400 |
| PHASE 0 RAPID DEPOLARISATION | 29 | 6.91e-01 | -0.042700 | 0.86400 |
| NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 66 | 5.50e-01 | 0.042600 | 0.78600 |
| IRAK4 DEFICIENCY TLR2 4 | 13 | 7.91e-01 | 0.042400 | 0.91400 |
| B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION | 48 | 6.12e-01 | 0.042300 | 0.82600 |
| COLLAGEN FORMATION | 80 | 5.14e-01 | -0.042200 | 0.76100 |
| FORMATION OF RNA POL II ELONGATION COMPLEX | 57 | 5.82e-01 | 0.042100 | 0.81300 |
| ADHERENS JUNCTIONS INTERACTIONS | 31 | 6.85e-01 | -0.042100 | 0.86100 |
| DNA DAMAGE BYPASS | 48 | 6.14e-01 | 0.042100 | 0.82700 |
| P75NTR SIGNALS VIA NF KB | 16 | 7.71e-01 | 0.042000 | 0.90600 |
| CROSSLINKING OF COLLAGEN FIBRILS | 17 | 7.64e-01 | 0.042000 | 0.90500 |
| INFLAMMASOMES | 19 | 7.52e-01 | 0.041900 | 0.90000 |
| PROTEIN UBIQUITINATION | 69 | 5.49e-01 | -0.041700 | 0.78600 |
| DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | 26 | 7.14e-01 | -0.041500 | 0.87400 |
| ERBB2 ACTIVATES PTK6 SIGNALING | 11 | 8.12e-01 | 0.041400 | 0.92600 |
| GRB2 EVENTS IN ERBB2 SIGNALING | 14 | 7.90e-01 | -0.041100 | 0.91400 |
| CELLULAR SENESCENCE | 145 | 3.94e-01 | -0.041000 | 0.67900 |
| DEADENYLATION DEPENDENT MRNA DECAY | 55 | 6.00e-01 | -0.040900 | 0.82500 |
| PCP CE PATHWAY | 90 | 5.06e-01 | 0.040600 | 0.75600 |
| ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 28 | 7.15e-01 | 0.039900 | 0.87400 |
| GLYCOGEN STORAGE DISEASES | 12 | 8.12e-01 | 0.039700 | 0.92600 |
| SIGNALING BY NOTCH2 | 33 | 6.94e-01 | 0.039600 | 0.86400 |
| INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | 13 | 8.06e-01 | -0.039400 | 0.92300 |
| HIV TRANSCRIPTION INITIATION | 45 | 6.48e-01 | 0.039300 | 0.83800 |
| RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL | 59 | 6.05e-01 | 0.038900 | 0.82500 |
| C TYPE LECTIN RECEPTORS CLRS | 111 | 4.83e-01 | -0.038600 | 0.74200 |
| PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | 15 | 7.96e-01 | 0.038500 | 0.92000 |
| P75NTR RECRUITS SIGNALLING COMPLEXES | 13 | 8.10e-01 | 0.038500 | 0.92600 |
| DEGRADATION OF DVL | 55 | 6.22e-01 | -0.038400 | 0.83100 |
| HDR THROUGH MMEJ ALT NHEJ | 10 | 8.34e-01 | -0.038200 | 0.93700 |
| RHOH GTPASE CYCLE | 37 | 6.91e-01 | 0.037800 | 0.86400 |
| LEISHMANIA INFECTION | 191 | 3.71e-01 | -0.037600 | 0.66100 |
| RAB GEFS EXCHANGE GTP FOR GDP ON RABS | 89 | 5.43e-01 | -0.037300 | 0.78400 |
| IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 48 | 6.57e-01 | 0.037100 | 0.84400 |
| AMYLOID FIBER FORMATION | 58 | 6.32e-01 | 0.036400 | 0.83400 |
| REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION | 84 | 5.68e-01 | 0.036000 | 0.80000 |
| BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA | 16 | 8.06e-01 | 0.035600 | 0.92300 |
| PI 3K CASCADE FGFR3 | 13 | 8.25e-01 | 0.035400 | 0.93300 |
| RAB GERANYLGERANYLATION | 59 | 6.40e-01 | 0.035200 | 0.83700 |
| PROCESSING OF DNA DOUBLE STRAND BREAK ENDS | 72 | 6.07e-01 | -0.035100 | 0.82500 |
| DNA REPLICATION PRE INITIATION | 79 | 5.93e-01 | 0.034800 | 0.82100 |
| TRANSPORT OF SMALL MOLECULES | 568 | 1.59e-01 | 0.034700 | 0.44400 |
| ADAPTIVE IMMUNE SYSTEM | 603 | 1.48e-01 | -0.034600 | 0.43100 |
| TRANSCRIPTIONAL REGULATION BY TP53 | 342 | 2.80e-01 | -0.034100 | 0.58400 |
| SHC1 EVENTS IN ERBB4 SIGNALING | 12 | 8.38e-01 | -0.034000 | 0.93900 |
| NEDDYLATION | 219 | 3.92e-01 | 0.033600 | 0.67900 |
| ASPARAGINE N LINKED GLYCOSYLATION | 283 | 3.33e-01 | -0.033500 | 0.63000 |
| ION CHANNEL TRANSPORT | 139 | 5.00e-01 | 0.033200 | 0.75200 |
| SIGNALING BY GPCR | 458 | 2.26e-01 | -0.033100 | 0.52400 |
| COPII MEDIATED VESICLE TRANSPORT | 65 | 6.45e-01 | 0.033100 | 0.83800 |
| REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS | 14 | 8.32e-01 | 0.032700 | 0.93600 |
| NEGATIVE REGULATION OF FGFR1 SIGNALING | 25 | 7.78e-01 | -0.032500 | 0.90900 |
| CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX | 10 | 8.59e-01 | 0.032400 | 0.94600 |
| ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | 288 | 3.45e-01 | -0.032400 | 0.64100 |
| SHC MEDIATED CASCADE FGFR4 | 11 | 8.53e-01 | -0.032200 | 0.94300 |
| HEDGEHOG OFF STATE | 106 | 5.67e-01 | -0.032200 | 0.79900 |
| COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 86 | 6.08e-01 | 0.032100 | 0.82500 |
| STABILIZATION OF P53 | 54 | 6.85e-01 | -0.031900 | 0.86100 |
| GPVI MEDIATED ACTIVATION CASCADE | 31 | 7.60e-01 | -0.031700 | 0.90400 |
| ION HOMEOSTASIS | 49 | 7.02e-01 | -0.031600 | 0.86800 |
| CELL CYCLE CHECKPOINTS | 245 | 3.96e-01 | -0.031500 | 0.67900 |
| RHO GTPASE EFFECTORS | 251 | 3.91e-01 | -0.031500 | 0.67900 |
| SENSORY PROCESSING OF SOUND | 61 | 6.71e-01 | 0.031500 | 0.85300 |
| INTEGRIN CELL SURFACE INTERACTIONS | 71 | 6.51e-01 | 0.031100 | 0.83900 |
| FCGR ACTIVATION | 10 | 8.65e-01 | -0.031000 | 0.94800 |
| RHO GTPASES ACTIVATE ROCKS | 19 | 8.17e-01 | 0.030700 | 0.92900 |
| TCF DEPENDENT SIGNALING IN RESPONSE TO WNT | 177 | 4.82e-01 | -0.030700 | 0.74200 |
| PLATELET CALCIUM HOMEOSTASIS | 26 | 7.88e-01 | 0.030500 | 0.91300 |
| TNFR2 NON CANONICAL NF KB PATHWAY | 80 | 6.39e-01 | -0.030300 | 0.83700 |
| FRS MEDIATED FGFR4 SIGNALING | 13 | 8.51e-01 | 0.030100 | 0.94300 |
| MITOTIC PROPHASE | 94 | 6.15e-01 | -0.030100 | 0.82700 |
| REGULATION OF RUNX3 EXPRESSION AND ACTIVITY | 53 | 7.12e-01 | -0.029300 | 0.87300 |
| RND1 GTPASE CYCLE | 38 | 7.55e-01 | -0.029300 | 0.90100 |
| E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS | 49 | 7.23e-01 | -0.029300 | 0.87700 |
| INFECTIOUS DISEASE | 724 | 1.82e-01 | -0.029300 | 0.47200 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 19 | 8.29e-01 | -0.028600 | 0.93500 |
| MITOTIC G1 PHASE AND G1 S TRANSITION | 142 | 5.57e-01 | 0.028600 | 0.79300 |
| RECYCLING PATHWAY OF L1 | 40 | 7.55e-01 | 0.028500 | 0.90100 |
| SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | 62 | 6.98e-01 | 0.028500 | 0.86700 |
| KINESINS | 48 | 7.33e-01 | -0.028400 | 0.88700 |
| RHO GTPASES ACTIVATE IQGAPS | 23 | 8.14e-01 | -0.028400 | 0.92600 |
| HDR THROUGH HOMOLOGOUS RECOMBINATION HRR | 63 | 7.04e-01 | 0.027700 | 0.86800 |
| SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 20 | 8.31e-01 | 0.027600 | 0.93500 |
| IRAK1 RECRUITS IKK COMPLEX | 14 | 8.61e-01 | -0.027100 | 0.94600 |
| ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION | 112 | 6.22e-01 | -0.027000 | 0.83100 |
| RAC3 GTPASE CYCLE | 88 | 6.64e-01 | 0.026800 | 0.84800 |
| NEGATIVE REGULATION OF FLT3 | 15 | 8.58e-01 | 0.026800 | 0.94500 |
| ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES | 53 | 7.37e-01 | -0.026700 | 0.88900 |
| TRANSCRIPTIONAL REGULATION BY SMALL RNAS | 62 | 7.16e-01 | -0.026700 | 0.87500 |
| PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 12 | 8.73e-01 | 0.026600 | 0.95200 |
| GLUCAGON TYPE LIGAND RECEPTORS | 25 | 8.22e-01 | -0.026000 | 0.93100 |
| METABOLISM OF POLYAMINES | 56 | 7.37e-01 | 0.025900 | 0.88900 |
| HDR THROUGH SINGLE STRAND ANNEALING SSA | 36 | 7.88e-01 | 0.025900 | 0.91300 |
| COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC | 44 | 7.68e-01 | -0.025700 | 0.90500 |
| BETA CATENIN INDEPENDENT WNT SIGNALING | 138 | 6.03e-01 | -0.025700 | 0.82500 |
| SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL | 26 | 8.21e-01 | 0.025600 | 0.93100 |
| INNATE IMMUNE SYSTEM | 780 | 2.29e-01 | -0.025500 | 0.52900 |
| NR1H2 AND NR1H3 MEDIATED SIGNALING | 38 | 7.86e-01 | -0.025400 | 0.91300 |
| STIMULI SENSING CHANNELS | 75 | 7.05e-01 | 0.025300 | 0.86800 |
| PLATELET ACTIVATION SIGNALING AND AGGREGATION | 224 | 5.14e-01 | -0.025300 | 0.76100 |
| SPRY REGULATION OF FGF SIGNALING | 16 | 8.61e-01 | -0.025200 | 0.94600 |
| INTRA GOLGI TRAFFIC | 43 | 7.76e-01 | -0.025100 | 0.90800 |
| MEMBRANE TRAFFICKING | 578 | 3.08e-01 | -0.024900 | 0.60300 |
| TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1 | 15 | 8.68e-01 | -0.024700 | 0.94800 |
| SIGNALING BY NUCLEAR RECEPTORS | 221 | 5.27e-01 | -0.024700 | 0.77200 |
| INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 29 | 8.18e-01 | -0.024700 | 0.93000 |
| CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | 46 | 7.73e-01 | 0.024600 | 0.90700 |
| JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 22 | 8.42e-01 | -0.024600 | 0.94100 |
| SIGNALING BY ROBO RECEPTORS | 204 | 5.47e-01 | 0.024500 | 0.78600 |
| G1 S DNA DAMAGE CHECKPOINTS | 65 | 7.34e-01 | -0.024400 | 0.88700 |
| AGGREPHAGY | 35 | 8.03e-01 | 0.024400 | 0.92200 |
| PINK1 PRKN MEDIATED MITOPHAGY | 22 | 8.44e-01 | 0.024200 | 0.94100 |
| PROGRAMMED CELL DEATH | 188 | 5.80e-01 | 0.023400 | 0.81100 |
| DNA DOUBLE STRAND BREAK RESPONSE | 53 | 7.70e-01 | 0.023200 | 0.90600 |
| TP53 REGULATES METABOLIC GENES | 85 | 7.12e-01 | -0.023200 | 0.87300 |
| RESPONSE OF MTB TO PHAGOCYTOSIS | 22 | 8.51e-01 | -0.023200 | 0.94300 |
| HEME BIOSYNTHESIS | 13 | 8.85e-01 | -0.023200 | 0.95500 |
| VESICLE MEDIATED TRANSPORT | 609 | 3.33e-01 | -0.023100 | 0.63000 |
| CELLULAR RESPONSE TO HYPOXIA | 72 | 7.35e-01 | 0.023100 | 0.88800 |
| CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA | 59 | 7.61e-01 | -0.022900 | 0.90500 |
| NON INTEGRIN MEMBRANE ECM INTERACTIONS | 57 | 7.69e-01 | -0.022500 | 0.90600 |
| REGULATION OF BETA CELL DEVELOPMENT | 26 | 8.43e-01 | -0.022500 | 0.94100 |
| SEPARATION OF SISTER CHROMATIDS | 169 | 6.16e-01 | -0.022400 | 0.82700 |
| THE PHOTOTRANSDUCTION CASCADE | 19 | 8.67e-01 | 0.022300 | 0.94800 |
| NEGATIVE REGULATION OF FGFR4 SIGNALING | 22 | 8.58e-01 | 0.022100 | 0.94500 |
| SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES | 30 | 8.35e-01 | -0.022000 | 0.93700 |
| RIPK1 MEDIATED REGULATED NECROSIS | 25 | 8.49e-01 | -0.022000 | 0.94300 |
| JOSEPHIN DOMAIN DUBS | 11 | 9.00e-01 | -0.022000 | 0.96000 |
| RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA | 24 | 8.53e-01 | 0.021800 | 0.94300 |
| CELLULAR RESPONSES TO EXTERNAL STIMULI | 605 | 3.65e-01 | -0.021700 | 0.65800 |
| RNA POLYMERASE I TRANSCRIPTION INITIATION | 47 | 8.00e-01 | -0.021400 | 0.92000 |
| DISORDERS OF TRANSMEMBRANE TRANSPORTERS | 140 | 6.67e-01 | -0.021100 | 0.85100 |
| G2 M DNA DAMAGE CHECKPOINT | 66 | 7.74e-01 | -0.020400 | 0.90700 |
| CLATHRIN MEDIATED ENDOCYTOSIS | 132 | 6.88e-01 | -0.020300 | 0.86300 |
| FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 18 | 8.82e-01 | -0.020200 | 0.95500 |
| TRNA PROCESSING | 105 | 7.23e-01 | -0.020000 | 0.87700 |
| CELL CELL COMMUNICATION | 109 | 7.18e-01 | -0.020000 | 0.87500 |
| CARGO CONCENTRATION IN THE ER | 30 | 8.50e-01 | -0.020000 | 0.94300 |
| ABC TRANSPORTER DISORDERS | 69 | 7.74e-01 | 0.020000 | 0.90700 |
| TELOMERE C STRAND SYNTHESIS INITIATION | 13 | 9.01e-01 | 0.019800 | 0.96000 |
| INFLUENZA INFECTION | 145 | 6.81e-01 | -0.019800 | 0.85900 |
| SHC MEDIATED CASCADE FGFR3 | 13 | 9.02e-01 | 0.019800 | 0.96000 |
| MITOTIC METAPHASE AND ANAPHASE | 209 | 6.26e-01 | -0.019600 | 0.83100 |
| ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING | 10 | 9.15e-01 | 0.019500 | 0.96400 |
| HCMV LATE EVENTS | 66 | 7.85e-01 | -0.019400 | 0.91300 |
| RHO GTPASES ACTIVATE PAKS | 21 | 8.78e-01 | -0.019400 | 0.95300 |
| DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX | 82 | 7.63e-01 | 0.019200 | 0.90500 |
| G1 S SPECIFIC TRANSCRIPTION | 26 | 8.65e-01 | -0.019200 | 0.94800 |
| ZINC TRANSPORTERS | 15 | 8.98e-01 | -0.019200 | 0.96000 |
| APOPTOSIS | 166 | 6.73e-01 | 0.019000 | 0.85500 |
| SELECTIVE AUTOPHAGY | 72 | 7.81e-01 | -0.018900 | 0.91100 |
| FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX | 47 | 8.24e-01 | -0.018700 | 0.93200 |
| AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA | 53 | 8.20e-01 | -0.018100 | 0.93100 |
| CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY | 24 | 8.78e-01 | -0.018000 | 0.95300 |
| G0 AND EARLY G1 | 25 | 8.77e-01 | 0.017900 | 0.95300 |
| HOMOLOGY DIRECTED REPAIR | 109 | 7.47e-01 | -0.017900 | 0.89700 |
| ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS | 17 | 8.99e-01 | 0.017800 | 0.96000 |
| CARDIAC CONDUCTION | 107 | 7.51e-01 | -0.017800 | 0.90000 |
| AMINO ACIDS REGULATE MTORC1 | 51 | 8.28e-01 | 0.017600 | 0.93400 |
| DNA DOUBLE STRAND BREAK REPAIR | 138 | 7.21e-01 | -0.017600 | 0.87700 |
| PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 237 | 6.47e-01 | -0.017300 | 0.83800 |
| RAS PROCESSING | 23 | 8.87e-01 | -0.017100 | 0.95600 |
| FGFR2 MUTANT RECEPTOR ACTIVATION | 26 | 8.84e-01 | 0.016600 | 0.95500 |
| TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX | 16 | 9.09e-01 | 0.016400 | 0.96400 |
| WNT5A DEPENDENT INTERNALIZATION OF FZD4 | 15 | 9.13e-01 | -0.016300 | 0.96400 |
| RHOG GTPASE CYCLE | 73 | 8.11e-01 | 0.016200 | 0.92600 |
| TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | 16 | 9.12e-01 | -0.016000 | 0.96400 |
| SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | 15 | 9.15e-01 | -0.016000 | 0.96400 |
| CILIUM ASSEMBLY | 190 | 7.05e-01 | 0.016000 | 0.86800 |
| ER TO GOLGI ANTEROGRADE TRANSPORT | 140 | 7.46e-01 | 0.015900 | 0.89600 |
| TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA | 16 | 9.13e-01 | 0.015800 | 0.96400 |
| RAC2 GTPASE CYCLE | 86 | 8.01e-01 | 0.015800 | 0.92100 |
| SARS COV 1 INFECTION | 48 | 8.53e-01 | 0.015400 | 0.94300 |
| COLLAGEN CHAIN TRIMERIZATION | 40 | 8.68e-01 | -0.015200 | 0.94800 |
| LAMININ INTERACTIONS | 29 | 8.90e-01 | -0.014800 | 0.95900 |
| DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE | 27 | 8.95e-01 | -0.014700 | 0.96000 |
| INTERLEUKIN 1 SIGNALING | 94 | 8.09e-01 | 0.014400 | 0.92600 |
| CYTOPROTECTION BY HMOX1 | 120 | 7.86e-01 | 0.014400 | 0.91300 |
| CYTOSOLIC TRNA AMINOACYLATION | 24 | 9.03e-01 | 0.014400 | 0.96000 |
| INCRETIN SYNTHESIS SECRETION AND INACTIVATION | 12 | 9.32e-01 | -0.014300 | 0.97100 |
| SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1 | 12 | 9.32e-01 | -0.014300 | 0.97100 |
| ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION | 85 | 8.21e-01 | 0.014200 | 0.93100 |
| DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS | 59 | 8.51e-01 | 0.014200 | 0.94300 |
| ACYL CHAIN REMODELLING OF PE | 17 | 9.20e-01 | 0.014100 | 0.96700 |
| DEGRADATION OF AXIN | 53 | 8.60e-01 | 0.014000 | 0.94600 |
| PI 3K CASCADE FGFR4 | 11 | 9.37e-01 | -0.013800 | 0.97200 |
| SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | 16 | 9.26e-01 | -0.013400 | 0.97000 |
| MITOTIC PROMETAPHASE | 178 | 7.59e-01 | -0.013300 | 0.90400 |
| MITOPHAGY | 29 | 9.01e-01 | -0.013300 | 0.96000 |
| GLUCOSE METABOLISM | 80 | 8.38e-01 | 0.013300 | 0.93900 |
| WNT LIGAND BIOGENESIS AND TRAFFICKING | 23 | 9.13e-01 | -0.013100 | 0.96400 |
| DEGRADATION OF GLI1 BY THE PROTEASOME | 57 | 8.65e-01 | 0.013000 | 0.94800 |
| CELL JUNCTION ORGANIZATION | 77 | 8.44e-01 | 0.013000 | 0.94100 |
| RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK | 48 | 8.79e-01 | -0.012700 | 0.95300 |
| INTERLEUKIN 12 FAMILY SIGNALING | 44 | 8.91e-01 | -0.011900 | 0.95900 |
| TRANSCRIPTIONAL REGULATION BY RUNX3 | 94 | 8.42e-01 | 0.011900 | 0.94100 |
| HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE | 40 | 8.96e-01 | 0.011900 | 0.96000 |
| CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS | 92 | 8.48e-01 | 0.011600 | 0.94300 |
| ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE | 96 | 8.45e-01 | 0.011500 | 0.94100 |
| INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC | 185 | 7.88e-01 | -0.011500 | 0.91300 |
| DEPOLYMERISATION OF THE NUCLEAR LAMINA | 13 | 9.43e-01 | -0.011400 | 0.97300 |
| PRE NOTCH EXPRESSION AND PROCESSING | 65 | 8.76e-01 | -0.011200 | 0.95300 |
| HEMOSTASIS | 477 | 6.79e-01 | 0.011100 | 0.85900 |
| PYROPTOSIS | 21 | 9.30e-01 | 0.011100 | 0.97100 |
| MRNA SPLICING | 188 | 7.97e-01 | 0.010900 | 0.92000 |
| ENDOGENOUS STEROLS | 20 | 9.34e-01 | -0.010700 | 0.97100 |
| CELL CYCLE | 596 | 6.59e-01 | -0.010600 | 0.84500 |
| TRANSFERRIN ENDOCYTOSIS AND RECYCLING | 26 | 9.26e-01 | -0.010600 | 0.97000 |
| BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS | 33 | 9.17e-01 | 0.010400 | 0.96600 |
| EGFR DOWNREGULATION | 27 | 9.26e-01 | -0.010400 | 0.97000 |
| TRIGLYCERIDE METABOLISM | 23 | 9.32e-01 | -0.010300 | 0.97100 |
| TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 29 | 9.25e-01 | 0.010100 | 0.97000 |
| METAL ION SLC TRANSPORTERS | 24 | 9.33e-01 | -0.009930 | 0.97100 |
| FCERI MEDIATED NF KB ACTIVATION | 76 | 8.83e-01 | -0.009760 | 0.95500 |
| EXTENSION OF TELOMERES | 49 | 9.06e-01 | 0.009710 | 0.96300 |
| TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | 169 | 8.31e-01 | 0.009530 | 0.93500 |
| TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS | 28 | 9.32e-01 | -0.009280 | 0.97100 |
| POST TRANSLATIONAL PROTEIN MODIFICATION | 1217 | 6.18e-01 | -0.008570 | 0.82800 |
| ABC TRANSPORTERS IN LIPID HOMEOSTASIS | 13 | 9.58e-01 | -0.008440 | 0.98200 |
| RHOD GTPASE CYCLE | 50 | 9.19e-01 | -0.008280 | 0.96700 |
| INTERLEUKIN 1 FAMILY SIGNALING | 121 | 8.81e-01 | 0.007860 | 0.95500 |
| METABOLISM OF LIPIDS | 615 | 7.41e-01 | 0.007850 | 0.89100 |
| SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | 11 | 9.64e-01 | 0.007780 | 0.98300 |
| ACTIVATION OF BH3 ONLY PROTEINS | 30 | 9.41e-01 | 0.007760 | 0.97200 |
| ABC FAMILY PROTEINS MEDIATED TRANSPORT | 93 | 8.98e-01 | -0.007690 | 0.96000 |
| CLEC7A DECTIN 1 SIGNALING | 93 | 8.99e-01 | 0.007620 | 0.96000 |
| THE NLRP3 INFLAMMASOME | 15 | 9.61e-01 | -0.007360 | 0.98200 |
| CELL CYCLE MITOTIC | 479 | 7.86e-01 | -0.007270 | 0.91300 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 28 | 9.48e-01 | 0.007130 | 0.97700 |
| NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS | 23 | 9.53e-01 | -0.007110 | 0.98100 |
| REGULATED NECROSIS | 46 | 9.35e-01 | -0.006920 | 0.97100 |
| INFECTION WITH MYCOBACTERIUM TUBERCULOSIS | 25 | 9.54e-01 | -0.006600 | 0.98100 |
| MUSCLE CONTRACTION | 159 | 8.98e-01 | 0.005910 | 0.96000 |
| NUCLEAR ENVELOPE NE REASSEMBLY | 63 | 9.36e-01 | -0.005880 | 0.97100 |
| INTRINSIC PATHWAY FOR APOPTOSIS | 52 | 9.42e-01 | 0.005870 | 0.97200 |
| DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING | 58 | 9.38e-01 | 0.005870 | 0.97200 |
| ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS | 24 | 9.62e-01 | -0.005580 | 0.98200 |
| G2 M CHECKPOINTS | 133 | 9.12e-01 | 0.005570 | 0.96400 |
| HIV LIFE CYCLE | 142 | 9.09e-01 | 0.005550 | 0.96400 |
| SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX | 12 | 9.74e-01 | -0.005470 | 0.98900 |
| HIV INFECTION | 218 | 8.93e-01 | -0.005290 | 0.96000 |
| TRANS GOLGI NETWORK VESICLE BUDDING | 69 | 9.41e-01 | -0.005130 | 0.97200 |
| ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES | 10 | 9.79e-01 | -0.004850 | 0.98900 |
| M PHASE | 343 | 8.84e-01 | -0.004600 | 0.95500 |
| TCR SIGNALING | 99 | 9.39e-01 | 0.004430 | 0.97200 |
| ACYL CHAIN REMODELLING OF PS | 15 | 9.76e-01 | -0.004400 | 0.98900 |
| ERBB2 REGULATES CELL MOTILITY | 13 | 9.79e-01 | -0.004300 | 0.98900 |
| RND2 GTPASE CYCLE | 38 | 9.64e-01 | 0.004210 | 0.98300 |
| POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION | 63 | 9.55e-01 | -0.004120 | 0.98100 |
| GOLGI ASSOCIATED VESICLE BIOGENESIS | 54 | 9.58e-01 | -0.004120 | 0.98200 |
| GLUTAMATE AND GLUTAMINE METABOLISM | 13 | 9.80e-01 | -0.004000 | 0.98900 |
| METABOLISM OF RNA | 643 | 8.69e-01 | 0.003830 | 0.94800 |
| BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | 76 | 9.54e-01 | 0.003820 | 0.98100 |
| N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | 24 | 9.74e-01 | -0.003780 | 0.98900 |
| HEDGEHOG LIGAND BIOGENESIS | 61 | 9.61e-01 | -0.003620 | 0.98200 |
| THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT | 66 | 9.60e-01 | -0.003600 | 0.98200 |
| PLASMA LIPOPROTEIN CLEARANCE | 26 | 9.75e-01 | 0.003490 | 0.98900 |
| RHOF GTPASE CYCLE | 40 | 9.71e-01 | -0.003310 | 0.98800 |
| ENOS ACTIVATION | 11 | 9.88e-01 | 0.002670 | 0.99300 |
| SURFACTANT METABOLISM | 17 | 9.85e-01 | -0.002640 | 0.99200 |
| RNA POLYMERASE III TRANSCRIPTION | 41 | 9.77e-01 | -0.002630 | 0.98900 |
| NEUTROPHIL DEGRANULATION | 388 | 9.34e-01 | -0.002460 | 0.97100 |
| TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | 13 | 9.89e-01 | 0.002250 | 0.99300 |
| MITOTIC G2 G2 M PHASES | 184 | 9.61e-01 | 0.002120 | 0.98200 |
| SPHINGOLIPID METABOLISM | 80 | 9.76e-01 | 0.001910 | 0.98900 |
| AUTOPHAGY | 138 | 9.69e-01 | 0.001910 | 0.98700 |
| G ALPHA S SIGNALLING EVENTS | 98 | 9.83e-01 | -0.001240 | 0.99100 |
| FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | 120 | 9.83e-01 | 0.001140 | 0.99100 |
| COPI MEDIATED ANTEROGRADE TRANSPORT | 90 | 9.86e-01 | -0.001060 | 0.99200 |
| BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS | 11 | 9.96e-01 | -0.000982 | 0.99700 |
| MET ACTIVATES PTK2 SIGNALING | 29 | 9.96e-01 | -0.000548 | 0.99700 |
| TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES | 61 | 9.94e-01 | 0.000525 | 0.99700 |
| CELL EXTRACELLULAR MATRIX INTERACTIONS | 18 | 9.97e-01 | -0.000505 | 0.99700 |
| GOLGI TO ER RETROGRADE TRANSPORT | 119 | 9.94e-01 | 0.000431 | 0.99700 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
| 82 | |
|---|---|
| set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES |
| setSize | 10 |
| pANOVA | 0.000287 |
| s.dist | -0.662 |
| p.adjustANOVA | 0.0151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hspa5 | -9106 |
| Xbp1 | -9097 |
| Ddit3 | -9045 |
| Calr | -9044 |
| Hsp90b1 | -8902 |
| Atf4 | -7975 |
| Nfya | -6743 |
| Nfyb | -3792 |
| Atf6 | -2502 |
| Nfyc | 3753 |
| GeneID | Gene Rank |
|---|---|
| Hspa5 | -9106 |
| Xbp1 | -9097 |
| Ddit3 | -9045 |
| Calr | -9044 |
| Hsp90b1 | -8902 |
| Atf4 | -7975 |
| Nfya | -6743 |
| Nfyb | -3792 |
| Atf6 | -2502 |
| Nfyc | 3753 |
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K
| 299 | |
|---|---|
| set | ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K |
| setSize | 11 |
| pANOVA | 0.000264 |
| s.dist | -0.635 |
| p.adjustANOVA | 0.0151 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pik3r5 | -8754 |
| Gab1 | -8584 |
| Pik3ca | -8013 |
| Jak2 | -7896 |
| Lyn | -7599 |
| Pik3cd | -7557 |
| Epor | -6149 |
| Pik3cg | -5866 |
| Pik3cb | -5533 |
| Irs2 | -1397 |
| Pik3r1 | 1171 |
| GeneID | Gene Rank |
|---|---|
| Pik3r5 | -8754 |
| Gab1 | -8584 |
| Pik3ca | -8013 |
| Jak2 | -7896 |
| Lyn | -7599 |
| Pik3cd | -7557 |
| Epor | -6149 |
| Pik3cg | -5866 |
| Pik3cb | -5533 |
| Irs2 | -1397 |
| Pik3r1 | 1171 |
FORMATION OF FIBRIN CLOT CLOTTING CASCADE
| 330 | |
|---|---|
| set | FORMATION OF FIBRIN CLOT CLOTTING CASCADE |
| setSize | 19 |
| pANOVA | 2.49e-06 |
| s.dist | 0.624 |
| p.adjustANOVA | 0.00122 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| F3 | 7824 |
| F2r | 7820 |
| A2m | 7807 |
| Serping1 | 7494 |
| Pros1 | 7133 |
| F8 | 7087 |
| Gp5 | 6795 |
| C1qbp | 6505 |
| Tfpi | 6002 |
| Vwf | 5862 |
| Serpine2 | 4803 |
| Prtn3 | 4378 |
| F5 | 3717 |
| Thbd | 3602 |
| Serpind1 | 3476 |
| Gp1ba | 3023 |
| Serpinc1 | 2244 |
| F13a1 | 1780 |
| Prcp | -9023 |
| GeneID | Gene Rank |
|---|---|
| F3 | 7824 |
| F2r | 7820 |
| A2m | 7807 |
| Serping1 | 7494 |
| Pros1 | 7133 |
| F8 | 7087 |
| Gp5 | 6795 |
| C1qbp | 6505 |
| Tfpi | 6002 |
| Vwf | 5862 |
| Serpine2 | 4803 |
| Prtn3 | 4378 |
| F5 | 3717 |
| Thbd | 3602 |
| Serpind1 | 3476 |
| Gp1ba | 3023 |
| Serpinc1 | 2244 |
| F13a1 | 1780 |
| Prcp | -9023 |
COMMON PATHWAY OF FIBRIN CLOT FORMATION
| 169 | |
|---|---|
| set | COMMON PATHWAY OF FIBRIN CLOT FORMATION |
| setSize | 10 |
| pANOVA | 0.00071 |
| s.dist | 0.618 |
| p.adjustANOVA | 0.0252 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| F2r | 7820 |
| Pros1 | 7133 |
| F8 | 7087 |
| Serpine2 | 4803 |
| Prtn3 | 4378 |
| F5 | 3717 |
| Thbd | 3602 |
| Serpind1 | 3476 |
| Serpinc1 | 2244 |
| F13a1 | 1780 |
| GeneID | Gene Rank |
|---|---|
| F2r | 7820 |
| Pros1 | 7133 |
| F8 | 7087 |
| Serpine2 | 4803 |
| Prtn3 | 4378 |
| F5 | 3717 |
| Thbd | 3602 |
| Serpind1 | 3476 |
| Serpinc1 | 2244 |
| F13a1 | 1780 |
INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION
| 490 | |
|---|---|
| set | INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION |
| setSize | 12 |
| pANOVA | 0.000332 |
| s.dist | 0.598 |
| p.adjustANOVA | 0.0156 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| A2m | 7807 |
| Serping1 | 7494 |
| Pros1 | 7133 |
| F8 | 7087 |
| Gp5 | 6795 |
| C1qbp | 6505 |
| Vwf | 5862 |
| Serpine2 | 4803 |
| Serpind1 | 3476 |
| Gp1ba | 3023 |
| Serpinc1 | 2244 |
| Prcp | -9023 |
| GeneID | Gene Rank |
|---|---|
| A2m | 7807 |
| Serping1 | 7494 |
| Pros1 | 7133 |
| F8 | 7087 |
| Gp5 | 6795 |
| C1qbp | 6505 |
| Vwf | 5862 |
| Serpine2 | 4803 |
| Serpind1 | 3476 |
| Gp1ba | 3023 |
| Serpinc1 | 2244 |
| Prcp | -9023 |
BIOTIN TRANSPORT AND METABOLISM
| 101 | |
|---|---|
| set | BIOTIN TRANSPORT AND METABOLISM |
| setSize | 11 |
| pANOVA | 0.0016 |
| s.dist | 0.549 |
| p.adjustANOVA | 0.0408 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mccc2 | 7514 |
| Pccb | 7216 |
| Hlcs | 7120 |
| Acacb | 6630 |
| Slc5a6 | 5683 |
| Pcx | 5621 |
| Btd | 4865 |
| Pcca | 2385 |
| Mccc1 | 1693 |
| Pdzd11 | 1614 |
| Acaca | -6112 |
| GeneID | Gene Rank |
|---|---|
| Mccc2 | 7514 |
| Pccb | 7216 |
| Hlcs | 7120 |
| Acacb | 6630 |
| Slc5a6 | 5683 |
| Pcx | 5621 |
| Btd | 4865 |
| Pcca | 2385 |
| Mccc1 | 1693 |
| Pdzd11 | 1614 |
| Acaca | -6112 |
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS
| 45 | |
|---|---|
| set | AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS |
| setSize | 10 |
| pANOVA | 0.00874 |
| s.dist | -0.479 |
| p.adjustANOVA | 0.112 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Creb1 | -8839 |
| Akt2 | -8711 |
| Nr4a1 | -8436 |
| Akt3 | -6179 |
| Rps6kb2 | -5991 |
| Foxo4 | -4967 |
| Foxo1 | -2069 |
| Foxo3 | -1534 |
| Foxo6 | -473 |
| Akt1 | 280 |
| GeneID | Gene Rank |
|---|---|
| Creb1 | -8839 |
| Akt2 | -8711 |
| Nr4a1 | -8436 |
| Akt3 | -6179 |
| Rps6kb2 | -5991 |
| Foxo4 | -4967 |
| Foxo1 | -2069 |
| Foxo3 | -1534 |
| Foxo6 | -473 |
| Akt1 | 280 |
ATTENUATION PHASE
| 84 | |
|---|---|
| set | ATTENUATION PHASE |
| setSize | 24 |
| pANOVA | 8.72e-05 |
| s.dist | -0.463 |
| p.adjustANOVA | 0.00731 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hspb1 | -9078 |
| Serpinh1 | -9056 |
| Dnajb1 | -9015 |
| Hsph1 | -9009 |
| Hspa1b | -8929 |
| Fkbp4 | -8926 |
| Hspa8 | -8841 |
| Hsp90aa1 | -8747 |
| Hspa1a | -8354 |
| Ptges3 | -8288 |
| Hsp90ab1 | -7515 |
| Dedd2 | -7215 |
| Crebbp | -6906 |
| Tnfrsf21 | -6854 |
| Ep300 | -3538 |
| Hsf1 | -2790 |
| Cryba4 | -2236 |
| Mrpl18 | -1627 |
| Hspa2 | -566 |
| Dnajb6 | 1427 |
| GeneID | Gene Rank |
|---|---|
| Hspb1 | -9078 |
| Serpinh1 | -9056 |
| Dnajb1 | -9015 |
| Hsph1 | -9009 |
| Hspa1b | -8929 |
| Fkbp4 | -8926 |
| Hspa8 | -8841 |
| Hsp90aa1 | -8747 |
| Hspa1a | -8354 |
| Ptges3 | -8288 |
| Hsp90ab1 | -7515 |
| Dedd2 | -7215 |
| Crebbp | -6906 |
| Tnfrsf21 | -6854 |
| Ep300 | -3538 |
| Hsf1 | -2790 |
| Cryba4 | -2236 |
| Mrpl18 | -1627 |
| Hspa2 | -566 |
| Dnajb6 | 1427 |
| Col4a6 | 1854 |
| Ubb | 3907 |
| Hsbp1 | 4807 |
| Hspa1l | 6260 |
LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME
| 521 | |
|---|---|
| set | LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME |
| setSize | 13 |
| pANOVA | 0.00425 |
| s.dist | -0.458 |
| p.adjustANOVA | 0.0745 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Bdnf | -8972 |
| Gps2 | -7695 |
| Tbl1x | -6921 |
| Calm1 | -6088 |
| Camk4 | -6010 |
| Tbl1xr1 | -5356 |
| Ncor1 | -5255 |
| Mecp2 | -5028 |
| Sin3a | -4327 |
| Ncor2 | -3759 |
| Hdac3 | -2903 |
| Hdac1 | 876 |
| Prkaca | 2759 |
| GeneID | Gene Rank |
|---|---|
| Bdnf | -8972 |
| Gps2 | -7695 |
| Tbl1x | -6921 |
| Calm1 | -6088 |
| Camk4 | -6010 |
| Tbl1xr1 | -5356 |
| Ncor1 | -5255 |
| Mecp2 | -5028 |
| Sin3a | -4327 |
| Ncor2 | -3759 |
| Hdac3 | -2903 |
| Hdac1 | 876 |
| Prkaca | 2759 |
PURINE CATABOLISM
| 757 | |
|---|---|
| set | PURINE CATABOLISM |
| setSize | 16 |
| pANOVA | 0.00169 |
| s.dist | 0.453 |
| p.adjustANOVA | 0.0416 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Xdh | 7727 |
| Nudt1 | 7672 |
| Nudt16 | 7477 |
| Nudt9 | 7452 |
| Nudt15 | 7324 |
| Nt5c | 7081 |
| Dnph1 | 6968 |
| Nt5e | 5797 |
| Nt5c2 | 5669 |
| Itpa | 1733 |
| Pnp2 | 1058 |
| Nt5c1a | 1052 |
| Nudt18 | -161 |
| Gda | -2811 |
| Nudt5 | -4317 |
| Adprm | -8429 |
| GeneID | Gene Rank |
|---|---|
| Xdh | 7727 |
| Nudt1 | 7672 |
| Nudt16 | 7477 |
| Nudt9 | 7452 |
| Nudt15 | 7324 |
| Nt5c | 7081 |
| Dnph1 | 6968 |
| Nt5e | 5797 |
| Nt5c2 | 5669 |
| Itpa | 1733 |
| Pnp2 | 1058 |
| Nt5c1a | 1052 |
| Nudt18 | -161 |
| Gda | -2811 |
| Nudt5 | -4317 |
| Adprm | -8429 |
P38MAPK EVENTS
| 676 | |
|---|---|
| set | P38MAPK EVENTS |
| setSize | 12 |
| pANOVA | 0.00681 |
| s.dist | -0.451 |
| p.adjustANOVA | 0.094 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Mapk12 | -8422 |
| Mapk11 | -8342 |
| Nras | -8330 |
| Ralb | -7441 |
| Rala | -6774 |
| Kras | -5974 |
| Mapkapk3 | -5823 |
| Mapk14 | -5719 |
| Src | -2599 |
| Hras | 593 |
| Ralgds | 2018 |
| Mapkapk2 | 3335 |
| GeneID | Gene Rank |
|---|---|
| Mapk12 | -8422 |
| Mapk11 | -8342 |
| Nras | -8330 |
| Ralb | -7441 |
| Rala | -6774 |
| Kras | -5974 |
| Mapkapk3 | -5823 |
| Mapk14 | -5719 |
| Src | -2599 |
| Hras | 593 |
| Ralgds | 2018 |
| Mapkapk2 | 3335 |
TRAF6 MEDIATED IRF7 ACTIVATION
| 1098 | |
|---|---|
| set | TRAF6 MEDIATED IRF7 ACTIVATION |
| setSize | 15 |
| pANOVA | 0.00262 |
| s.dist | -0.449 |
| p.adjustANOVA | 0.0543 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Irf7 | -9041 |
| Ddx58 | -8458 |
| Traf6 | -8423 |
| Traf2 | -7206 |
| Crebbp | -6906 |
| Sike1 | -6348 |
| Tank | -6171 |
| Irf3 | -5666 |
| Ikbke | -5263 |
| Trim25 | -4525 |
| Ep300 | -3538 |
| Ifih1 | -2922 |
| Mavs | -1124 |
| Tbk1 | 3219 |
| Rnf135 | 5837 |
| GeneID | Gene Rank |
|---|---|
| Irf7 | -9041 |
| Ddx58 | -8458 |
| Traf6 | -8423 |
| Traf2 | -7206 |
| Crebbp | -6906 |
| Sike1 | -6348 |
| Tank | -6171 |
| Irf3 | -5666 |
| Ikbke | -5263 |
| Trim25 | -4525 |
| Ep300 | -3538 |
| Ifih1 | -2922 |
| Mavs | -1124 |
| Tbk1 | 3219 |
| Rnf135 | 5837 |
SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION
| 913 | |
|---|---|
| set | SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION |
| setSize | 14 |
| pANOVA | 0.00439 |
| s.dist | -0.44 |
| p.adjustANOVA | 0.0746 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tln1 | -8767 |
| Fes | -8433 |
| Rnd1 | -7502 |
| Pip5k1c | -6913 |
| Sema3a | -5760 |
| Plxna4 | -5216 |
| Plxna3 | -5093 |
| Plxna2 | -4829 |
| Rras | -4790 |
| Nrp1 | -4424 |
| Plxna1 | -3551 |
| Rac1 | -2608 |
| Fyn | 2255 |
| Farp2 | 4594 |
| GeneID | Gene Rank |
|---|---|
| Tln1 | -8767 |
| Fes | -8433 |
| Rnd1 | -7502 |
| Pip5k1c | -6913 |
| Sema3a | -5760 |
| Plxna4 | -5216 |
| Plxna3 | -5093 |
| Plxna2 | -4829 |
| Rras | -4790 |
| Nrp1 | -4424 |
| Plxna1 | -3551 |
| Rac1 | -2608 |
| Fyn | 2255 |
| Farp2 | 4594 |
ERYTHROPOIETIN ACTIVATES RAS
| 300 | |
|---|---|
| set | ERYTHROPOIETIN ACTIVATES RAS |
| setSize | 13 |
| pANOVA | 0.00639 |
| s.dist | -0.437 |
| p.adjustANOVA | 0.0892 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Nras | -8330 |
| Jak2 | -7896 |
| Lyn | -7599 |
| Epor | -6149 |
| Kras | -5974 |
| Crkl | -5885 |
| Vav1 | -5708 |
| Sos1 | -5137 |
| Rapgef1 | -2981 |
| Irs2 | -1397 |
| Shc1 | -268 |
| Grb2 | 373 |
| Hras | 593 |
| GeneID | Gene Rank |
|---|---|
| Nras | -8330 |
| Jak2 | -7896 |
| Lyn | -7599 |
| Epor | -6149 |
| Kras | -5974 |
| Crkl | -5885 |
| Vav1 | -5708 |
| Sos1 | -5137 |
| Rapgef1 | -2981 |
| Irs2 | -1397 |
| Shc1 | -268 |
| Grb2 | 373 |
| Hras | 593 |
REGULATION OF RUNX1 EXPRESSION AND ACTIVITY
| 817 | |
|---|---|
| set | REGULATION OF RUNX1 EXPRESSION AND ACTIVITY |
| setSize | 17 |
| pANOVA | 0.00219 |
| s.dist | -0.429 |
| p.adjustANOVA | 0.0484 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ccnd1 | -9063 |
| Cbfb | -8799 |
| Ago3 | -8593 |
| Cdk6 | -8270 |
| Tnrc6b | -7781 |
| Ago2 | -7704 |
| Ago4 | -6947 |
| Ccnd2 | -6393 |
| Pml | -6276 |
| Mov10 | -5114 |
| Runx1 | -3172 |
| Src | -2599 |
| Tnrc6a | 21 |
| Ccnd3 | 412 |
| Ago1 | 2169 |
| Tnrc6c | 2469 |
| Ptpn11 | 3062 |
| GeneID | Gene Rank |
|---|---|
| Ccnd1 | -9063 |
| Cbfb | -8799 |
| Ago3 | -8593 |
| Cdk6 | -8270 |
| Tnrc6b | -7781 |
| Ago2 | -7704 |
| Ago4 | -6947 |
| Ccnd2 | -6393 |
| Pml | -6276 |
| Mov10 | -5114 |
| Runx1 | -3172 |
| Src | -2599 |
| Tnrc6a | 21 |
| Ccnd3 | 412 |
| Ago1 | 2169 |
| Tnrc6c | 2469 |
| Ptpn11 | 3062 |
SIGNALING BY FGFR4 IN DISEASE
| 956 | |
|---|---|
| set | SIGNALING BY FGFR4 IN DISEASE |
| setSize | 10 |
| pANOVA | 0.0188 |
| s.dist | -0.429 |
| p.adjustANOVA | 0.169 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gab1 | -8584 |
| Nras | -8330 |
| Pik3ca | -8013 |
| Kras | -5974 |
| Sos1 | -5137 |
| Frs2 | -5034 |
| Plcg1 | -3767 |
| Grb2 | 373 |
| Hras | 593 |
| Pik3r1 | 1171 |
| GeneID | Gene Rank |
|---|---|
| Gab1 | -8584 |
| Nras | -8330 |
| Pik3ca | -8013 |
| Kras | -5974 |
| Sos1 | -5137 |
| Frs2 | -5034 |
| Plcg1 | -3767 |
| Grb2 | 373 |
| Hras | 593 |
| Pik3r1 | 1171 |
MET ACTIVATES RAP1 AND RAC1
| 539 | |
|---|---|
| set | MET ACTIVATES RAP1 AND RAC1 |
| setSize | 11 |
| pANOVA | 0.0139 |
| s.dist | -0.428 |
| p.adjustANOVA | 0.147 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Gab1 | -8584 |
| Rap1a | -8221 |
| Met | -7240 |
| Hgf | -6642 |
| Crkl | -5885 |
| Rap1b | -5343 |
| Crk | -3639 |
| Rapgef1 | -2981 |
| Rac1 | -2608 |
| Grb2 | 373 |
| Dock7 | 3885 |
| GeneID | Gene Rank |
|---|---|
| Gab1 | -8584 |
| Rap1a | -8221 |
| Met | -7240 |
| Hgf | -6642 |
| Crkl | -5885 |
| Rap1b | -5343 |
| Crk | -3639 |
| Rapgef1 | -2981 |
| Rac1 | -2608 |
| Grb2 | 373 |
| Dock7 | 3885 |
MUCOPOLYSACCHARIDOSES
| 590 | |
|---|---|
| set | MUCOPOLYSACCHARIDOSES |
| setSize | 11 |
| pANOVA | 0.0142 |
| s.dist | 0.427 |
| p.adjustANOVA | 0.148 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Sgsh | 7432 |
| Glb1 | 6888 |
| Hyal1 | 6685 |
| Arsb | 5456 |
| Gns | 5182 |
| Galns | 4046 |
| Hgsnat | 3042 |
| Gusb | 1292 |
| Naglu | 883 |
| Ids | -1735 |
| Idua | -6363 |
| GeneID | Gene Rank |
|---|---|
| Sgsh | 7432 |
| Glb1 | 6888 |
| Hyal1 | 6685 |
| Arsb | 5456 |
| Gns | 5182 |
| Galns | 4046 |
| Hgsnat | 3042 |
| Gusb | 1292 |
| Naglu | 883 |
| Ids | -1735 |
| Idua | -6363 |
CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE
| 187 | |
|---|---|
| set | CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE |
| setSize | 11 |
| pANOVA | 0.02 |
| s.dist | -0.405 |
| p.adjustANOVA | 0.177 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Creb1 | -8839 |
| Adcy1 | -6202 |
| Calm1 | -6088 |
| Prkacb | -5917 |
| Prkar2b | -5890 |
| Prkx | -4782 |
| Prkar2a | -4612 |
| Prkar1b | -3627 |
| Prkar1a | -1916 |
| Adcy8 | 371 |
| Prkaca | 2759 |
| GeneID | Gene Rank |
|---|---|
| Creb1 | -8839 |
| Adcy1 | -6202 |
| Calm1 | -6088 |
| Prkacb | -5917 |
| Prkar2b | -5890 |
| Prkx | -4782 |
| Prkar2a | -4612 |
| Prkar1b | -3627 |
| Prkar1a | -1916 |
| Adcy8 | 371 |
| Prkaca | 2759 |
ATF6 ATF6 ALPHA ACTIVATES CHAPERONES
| 83 | |
|---|---|
| set | ATF6 ATF6 ALPHA ACTIVATES CHAPERONES |
| setSize | 12 |
| pANOVA | 0.0153 |
| s.dist | -0.404 |
| p.adjustANOVA | 0.155 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hspa5 | -9106 |
| Xbp1 | -9097 |
| Ddit3 | -9045 |
| Calr | -9044 |
| Hsp90b1 | -8902 |
| Atf4 | -7975 |
| Nfya | -6743 |
| Nfyb | -3792 |
| Atf6 | -2502 |
| Nfyc | 3753 |
| Mbtps2 | 5980 |
| Mbtps1 | 7759 |
| GeneID | Gene Rank |
|---|---|
| Hspa5 | -9106 |
| Xbp1 | -9097 |
| Ddit3 | -9045 |
| Calr | -9044 |
| Hsp90b1 | -8902 |
| Atf4 | -7975 |
| Nfya | -6743 |
| Nfyb | -3792 |
| Atf6 | -2502 |
| Nfyc | 3753 |
| Mbtps2 | 5980 |
| Mbtps1 | 7759 |
SEMA3A PAK DEPENDENT AXON REPULSION
| 912 | |
|---|---|
| set | SEMA3A PAK DEPENDENT AXON REPULSION |
| setSize | 16 |
| pANOVA | 0.00534 |
| s.dist | -0.402 |
| p.adjustANOVA | 0.0834 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hsp90aa1 | -8747 |
| Fes | -8433 |
| Hsp90ab1 | -7515 |
| Pak1 | -6645 |
| Sema3a | -5760 |
| Plxna4 | -5216 |
| Plxna3 | -5093 |
| Plxna2 | -4829 |
| Nrp1 | -4424 |
| Plxna1 | -3551 |
| Pak3 | -3417 |
| Rac1 | -2608 |
| Pak2 | -1312 |
| Limk1 | 253 |
| Cfl1 | 376 |
| Fyn | 2255 |
| GeneID | Gene Rank |
|---|---|
| Hsp90aa1 | -8747 |
| Fes | -8433 |
| Hsp90ab1 | -7515 |
| Pak1 | -6645 |
| Sema3a | -5760 |
| Plxna4 | -5216 |
| Plxna3 | -5093 |
| Plxna2 | -4829 |
| Nrp1 | -4424 |
| Plxna1 | -3551 |
| Pak3 | -3417 |
| Rac1 | -2608 |
| Pak2 | -1312 |
| Limk1 | 253 |
| Cfl1 | 376 |
| Fyn | 2255 |
TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
| 1096 | |
|---|---|
| set | TRAF3 DEPENDENT IRF ACTIVATION PATHWAY |
| setSize | 13 |
| pANOVA | 0.0121 |
| s.dist | -0.402 |
| p.adjustANOVA | 0.136 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Irf7 | -9041 |
| Ddx58 | -8458 |
| Traf3 | -7759 |
| Crebbp | -6906 |
| Sike1 | -6348 |
| Irf3 | -5666 |
| Ikbke | -5263 |
| Trim25 | -4525 |
| Ep300 | -3538 |
| Ifih1 | -2922 |
| Mavs | -1124 |
| Tbk1 | 3219 |
| Rnf135 | 5837 |
| GeneID | Gene Rank |
|---|---|
| Irf7 | -9041 |
| Ddx58 | -8458 |
| Traf3 | -7759 |
| Crebbp | -6906 |
| Sike1 | -6348 |
| Irf3 | -5666 |
| Ikbke | -5263 |
| Trim25 | -4525 |
| Ep300 | -3538 |
| Ifih1 | -2922 |
| Mavs | -1124 |
| Tbk1 | 3219 |
| Rnf135 | 5837 |
HSF1 ACTIVATION
| 431 | |
|---|---|
| set | HSF1 ACTIVATION |
| setSize | 26 |
| pANOVA | 0.000544 |
| s.dist | -0.392 |
| p.adjustANOVA | 0.0227 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hspb1 | -9078 |
| Serpinh1 | -9056 |
| Dnajb1 | -9015 |
| Hsph1 | -9009 |
| Hspa1b | -8929 |
| Fkbp4 | -8926 |
| Hsp90aa1 | -8747 |
| Hspa1a | -8354 |
| Ptges3 | -8288 |
| Hsp90ab1 | -7515 |
| Dedd2 | -7215 |
| Tnfrsf21 | -6854 |
| Hdac6 | -5561 |
| Rpa3 | -5289 |
| Vcp | -4958 |
| Hsf1 | -2790 |
| Cryba4 | -2236 |
| Mrpl18 | -1627 |
| Rpa1 | 145 |
| Dnajb6 | 1427 |
| GeneID | Gene Rank |
|---|---|
| Hspb1 | -9078 |
| Serpinh1 | -9056 |
| Dnajb1 | -9015 |
| Hsph1 | -9009 |
| Hspa1b | -8929 |
| Fkbp4 | -8926 |
| Hsp90aa1 | -8747 |
| Hspa1a | -8354 |
| Ptges3 | -8288 |
| Hsp90ab1 | -7515 |
| Dedd2 | -7215 |
| Tnfrsf21 | -6854 |
| Hdac6 | -5561 |
| Rpa3 | -5289 |
| Vcp | -4958 |
| Hsf1 | -2790 |
| Cryba4 | -2236 |
| Mrpl18 | -1627 |
| Rpa1 | 145 |
| Dnajb6 | 1427 |
| Col4a6 | 1854 |
| Ywhae | 2020 |
| Eef1a1 | 2455 |
| Ubb | 3907 |
| Rpa2 | 4095 |
| Hsbp1 | 4807 |
MITOCHONDRIAL FATTY ACID BETA OXIDATION
| 569 | |
|---|---|
| set | MITOCHONDRIAL FATTY ACID BETA OXIDATION |
| setSize | 33 |
| pANOVA | 0.000102 |
| s.dist | 0.391 |
| p.adjustANOVA | 0.00753 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Acaa2 | 7502 |
| Acadl | 7330 |
| Acot9 | 7257 |
| Pccb | 7216 |
| Echs1 | 7001 |
| Acad11 | 6872 |
| Mmut | 6862 |
| Dbi | 6761 |
| Acot11 | 6724 |
| Acot1 | 6353 |
| Acadm | 6015 |
| Acads | 5957 |
| Hadh | 5214 |
| Mcat | 4555 |
| Acbd6 | 4503 |
| Acsf2 | 4435 |
| Hadhb | 4346 |
| Acot3 | 3866 |
| Hadha | 3488 |
| Acot2 | 3263 |
| GeneID | Gene Rank |
|---|---|
| Acaa2 | 7502 |
| Acadl | 7330 |
| Acot9 | 7257 |
| Pccb | 7216 |
| Echs1 | 7001 |
| Acad11 | 6872 |
| Mmut | 6862 |
| Dbi | 6761 |
| Acot11 | 6724 |
| Acot1 | 6353 |
| Acadm | 6015 |
| Acads | 5957 |
| Hadh | 5214 |
| Mcat | 4555 |
| Acbd6 | 4503 |
| Acsf2 | 4435 |
| Hadhb | 4346 |
| Acot3 | 3866 |
| Hadha | 3488 |
| Acot2 | 3263 |
| Mcee | 2514 |
| Pcca | 2385 |
| Acot7 | 1890 |
| Eci1 | 1782 |
| Acot13 | 387 |
| Acadvl | 2 |
| Decr1 | -577 |
| Ndufab1 | -1865 |
| Mmaa | -6137 |
| Acad10 | -6538 |
| Mecr | -6593 |
| Pctp | -6794 |
| Them4 | -7789 |
SIGNALING BY ERYTHROPOIETIN
| 945 | |
|---|---|
| set | SIGNALING BY ERYTHROPOIETIN |
| setSize | 24 |
| pANOVA | 0.00103 |
| s.dist | -0.387 |
| p.adjustANOVA | 0.0317 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Pik3r5 | -8754 |
| Gab1 | -8584 |
| Nras | -8330 |
| Pik3ca | -8013 |
| Jak2 | -7896 |
| Lyn | -7599 |
| Pik3cd | -7557 |
| Epor | -6149 |
| Kras | -5974 |
| Crkl | -5885 |
| Pik3cg | -5866 |
| Vav1 | -5708 |
| Pik3cb | -5533 |
| Sos1 | -5137 |
| Plcg1 | -3767 |
| Rapgef1 | -2981 |
| Stat5b | -2741 |
| Irs2 | -1397 |
| Shc1 | -268 |
| Grb2 | 373 |
| GeneID | Gene Rank |
|---|---|
| Pik3r5 | -8754 |
| Gab1 | -8584 |
| Nras | -8330 |
| Pik3ca | -8013 |
| Jak2 | -7896 |
| Lyn | -7599 |
| Pik3cd | -7557 |
| Epor | -6149 |
| Kras | -5974 |
| Crkl | -5885 |
| Pik3cg | -5866 |
| Vav1 | -5708 |
| Pik3cb | -5533 |
| Sos1 | -5137 |
| Plcg1 | -3767 |
| Rapgef1 | -2981 |
| Stat5b | -2741 |
| Irs2 | -1397 |
| Shc1 | -268 |
| Grb2 | 373 |
| Hras | 593 |
| Pik3r1 | 1171 |
| Stat5a | 5779 |
| Plcg2 | 6338 |
PKA MEDIATED PHOSPHORYLATION OF CREB
| 710 | |
|---|---|
| set | PKA MEDIATED PHOSPHORYLATION OF CREB |
| setSize | 19 |
| pANOVA | 0.00353 |
| s.dist | -0.387 |
| p.adjustANOVA | 0.0646 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Creb1 | -8839 |
| Adcy3 | -8466 |
| Adcy4 | -7397 |
| Adcy2 | -6692 |
| Adcy1 | -6202 |
| Calm1 | -6088 |
| Prkacb | -5917 |
| Prkar2b | -5890 |
| Prkx | -4782 |
| Prkar2a | -4612 |
| Nbea | -4490 |
| Prkar1b | -3627 |
| Adcy9 | -3451 |
| Adcy6 | -2526 |
| Prkar1a | -1916 |
| Adcy8 | 371 |
| Adcy5 | 1393 |
| Adcy7 | 2102 |
| Prkaca | 2759 |
| GeneID | Gene Rank |
|---|---|
| Creb1 | -8839 |
| Adcy3 | -8466 |
| Adcy4 | -7397 |
| Adcy2 | -6692 |
| Adcy1 | -6202 |
| Calm1 | -6088 |
| Prkacb | -5917 |
| Prkar2b | -5890 |
| Prkx | -4782 |
| Prkar2a | -4612 |
| Nbea | -4490 |
| Prkar1b | -3627 |
| Adcy9 | -3451 |
| Adcy6 | -2526 |
| Prkar1a | -1916 |
| Adcy8 | 371 |
| Adcy5 | 1393 |
| Adcy7 | 2102 |
| Prkaca | 2759 |
RHOBTB2 GTPASE CYCLE
| 860 | |
|---|---|
| set | RHOBTB2 GTPASE CYCLE |
| setSize | 23 |
| pANOVA | 0.00137 |
| s.dist | -0.386 |
| p.adjustANOVA | 0.0366 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Rhobtb2 | -8953 |
| Phip | -8875 |
| Hsp90aa1 | -8747 |
| Cct7 | -8583 |
| Actn1 | -8032 |
| Stk38 | -7531 |
| Hsp90ab1 | -7515 |
| Cct2 | -6559 |
| Tra2b | -6528 |
| Tmod3 | -6033 |
| Dbn1 | -5305 |
| Cct6a | -5252 |
| Myo6 | -5143 |
| Ddx39b | -3691 |
| Actg1 | -3471 |
| Hnrnpc | -3354 |
| Srrm1 | -966 |
| Rbmx | 185 |
| Txnl1 | 1498 |
| Msi2 | 2730 |
| GeneID | Gene Rank |
|---|---|
| Rhobtb2 | -8953 |
| Phip | -8875 |
| Hsp90aa1 | -8747 |
| Cct7 | -8583 |
| Actn1 | -8032 |
| Stk38 | -7531 |
| Hsp90ab1 | -7515 |
| Cct2 | -6559 |
| Tra2b | -6528 |
| Tmod3 | -6033 |
| Dbn1 | -5305 |
| Cct6a | -5252 |
| Myo6 | -5143 |
| Ddx39b | -3691 |
| Actg1 | -3471 |
| Hnrnpc | -3354 |
| Srrm1 | -966 |
| Rbmx | 185 |
| Txnl1 | 1498 |
| Msi2 | 2730 |
| Twf1 | 3282 |
| Cul3 | 3457 |
| Cdc37 | 3721 |
MET ACTIVATES RAS SIGNALING
| 540 | |
|---|---|
| set | MET ACTIVATES RAS SIGNALING |
| setSize | 10 |
| pANOVA | 0.0369 |
| s.dist | -0.381 |
| p.adjustANOVA | 0.244 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Nras | -8330 |
| Ranbp10 | -7269 |
| Met | -7240 |
| Hgf | -6642 |
| Kras | -5974 |
| Sos1 | -5137 |
| Shc1 | -268 |
| Grb2 | 373 |
| Hras | 593 |
| Ranbp9 | 1248 |
| GeneID | Gene Rank |
|---|---|
| Nras | -8330 |
| Ranbp10 | -7269 |
| Met | -7240 |
| Hgf | -6642 |
| Kras | -5974 |
| Sos1 | -5137 |
| Shc1 | -268 |
| Grb2 | 373 |
| Hras | 593 |
| Ranbp9 | 1248 |
INTERLEUKIN 27 SIGNALING
| 476 | |
|---|---|
| set | INTERLEUKIN 27 SIGNALING |
| setSize | 10 |
| pANOVA | 0.0416 |
| s.dist | -0.372 |
| p.adjustANOVA | 0.254 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stat1 | -8227 |
| Jak2 | -7896 |
| Ebi3 | -7256 |
| Tyk2 | -5608 |
| Canx | -5301 |
| Crlf1 | -3949 |
| Il6st | -3203 |
| Stat3 | 82 |
| Jak1 | 249 |
| Il27ra | 3236 |
| GeneID | Gene Rank |
|---|---|
| Stat1 | -8227 |
| Jak2 | -7896 |
| Ebi3 | -7256 |
| Tyk2 | -5608 |
| Canx | -5301 |
| Crlf1 | -3949 |
| Il6st | -3203 |
| Stat3 | 82 |
| Jak1 | 249 |
| Il27ra | 3236 |
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS
| 27 | |
|---|---|
| set | ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS |
| setSize | 10 |
| pANOVA | 0.043 |
| s.dist | -0.37 |
| p.adjustANOVA | 0.259 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Fos | -9059 |
| Mapk11 | -8342 |
| Mapk8 | -6120 |
| Mapk14 | -5719 |
| Jun | -5333 |
| Mapk10 | -3657 |
| Atf2 | -2161 |
| Mapk9 | -905 |
| Mapk1 | 329 |
| Mapk3 | 3305 |
| GeneID | Gene Rank |
|---|---|
| Fos | -9059 |
| Mapk11 | -8342 |
| Mapk8 | -6120 |
| Mapk14 | -5719 |
| Jun | -5333 |
| Mapk10 | -3657 |
| Atf2 | -2161 |
| Mapk9 | -905 |
| Mapk1 | 329 |
| Mapk3 | 3305 |
CONSTITUTIVE SIGNALING BY EGFRVIII
| 175 | |
|---|---|
| set | CONSTITUTIVE SIGNALING BY EGFRVIII |
| setSize | 15 |
| pANOVA | 0.0134 |
| s.dist | -0.369 |
| p.adjustANOVA | 0.143 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hsp90aa1 | -8747 |
| Gab1 | -8584 |
| Nras | -8330 |
| Cbl | -8147 |
| Pik3ca | -8013 |
| Kras | -5974 |
| Egf | -5442 |
| Sos1 | -5137 |
| Plcg1 | -3767 |
| Shc1 | -268 |
| Egfr | 189 |
| Grb2 | 373 |
| Hras | 593 |
| Pik3r1 | 1171 |
| Cdc37 | 3721 |
| GeneID | Gene Rank |
|---|---|
| Hsp90aa1 | -8747 |
| Gab1 | -8584 |
| Nras | -8330 |
| Cbl | -8147 |
| Pik3ca | -8013 |
| Kras | -5974 |
| Egf | -5442 |
| Sos1 | -5137 |
| Plcg1 | -3767 |
| Shc1 | -268 |
| Egfr | 189 |
| Grb2 | 373 |
| Hras | 593 |
| Pik3r1 | 1171 |
| Cdc37 | 3721 |
INTERLEUKIN 35 SIGNALLING
| 478 | |
|---|---|
| set | INTERLEUKIN 35 SIGNALLING |
| setSize | 10 |
| pANOVA | 0.0491 |
| s.dist | -0.359 |
| p.adjustANOVA | 0.264 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stat1 | -8227 |
| Jak2 | -7896 |
| Ebi3 | -7256 |
| Tyk2 | -5608 |
| Canx | -5301 |
| Il6st | -3203 |
| Il12a | -2865 |
| Stat3 | 82 |
| Jak1 | 249 |
| Il27ra | 3236 |
| GeneID | Gene Rank |
|---|---|
| Stat1 | -8227 |
| Jak2 | -7896 |
| Ebi3 | -7256 |
| Tyk2 | -5608 |
| Canx | -5301 |
| Il6st | -3203 |
| Il12a | -2865 |
| Stat3 | 82 |
| Jak1 | 249 |
| Il27ra | 3236 |
EPHRIN SIGNALING
| 290 | |
|---|---|
| set | EPHRIN SIGNALING |
| setSize | 19 |
| pANOVA | 0.00692 |
| s.dist | -0.358 |
| p.adjustANOVA | 0.0944 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ephb3 | -9070 |
| Arhgef7 | -8541 |
| Efnb2 | -8225 |
| Pak1 | -6645 |
| Ephb1 | -6438 |
| Ephb6 | -5257 |
| Git1 | -4263 |
| Ephb4 | -4200 |
| Pak3 | -3417 |
| Sdcbp | -2816 |
| Rac1 | -2608 |
| Src | -2599 |
| Efnb1 | -2556 |
| Ephb2 | -2178 |
| Nck2 | -2057 |
| Pak2 | -1312 |
| Efnb3 | -1001 |
| Myl12a | 1289 |
| Fyn | 2255 |
| GeneID | Gene Rank |
|---|---|
| Ephb3 | -9070 |
| Arhgef7 | -8541 |
| Efnb2 | -8225 |
| Pak1 | -6645 |
| Ephb1 | -6438 |
| Ephb6 | -5257 |
| Git1 | -4263 |
| Ephb4 | -4200 |
| Pak3 | -3417 |
| Sdcbp | -2816 |
| Rac1 | -2608 |
| Src | -2599 |
| Efnb1 | -2556 |
| Ephb2 | -2178 |
| Nck2 | -2057 |
| Pak2 | -1312 |
| Efnb3 | -1001 |
| Myl12a | 1289 |
| Fyn | 2255 |
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS
| 545 | |
|---|---|
| set | METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS |
| setSize | 10 |
| pANOVA | 0.0524 |
| s.dist | 0.354 |
| p.adjustANOVA | 0.273 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Agt | 7754 |
| Ace | 6608 |
| Ctsd | 5001 |
| Ctsz | 3370 |
| Enpep | 3148 |
| Anpep | 1740 |
| Ace2 | 1208 |
| Atp6ap2 | 457 |
| Mme | -1631 |
| Aopep | -3987 |
| GeneID | Gene Rank |
|---|---|
| Agt | 7754 |
| Ace | 6608 |
| Ctsd | 5001 |
| Ctsz | 3370 |
| Enpep | 3148 |
| Anpep | 1740 |
| Ace2 | 1208 |
| Atp6ap2 | 457 |
| Mme | -1631 |
| Aopep | -3987 |
NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION
| 611 | |
|---|---|
| set | NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION |
| setSize | 21 |
| pANOVA | 0.00551 |
| s.dist | -0.35 |
| p.adjustANOVA | 0.0834 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Grin2a | -7764 |
| Lrrc7 | -7139 |
| Dlg4 | -6875 |
| Grin2b | -6798 |
| Actn2 | -6716 |
| Dlg1 | -6542 |
| Dlg3 | -6389 |
| Ppm1f | -6175 |
| Calm1 | -6088 |
| Camk4 | -6010 |
| Camk1 | -5655 |
| Dlg2 | -4965 |
| Camk2a | -4371 |
| Grin1 | -3658 |
| Nefl | -1421 |
| Ppm1e | -1341 |
| Camk2g | -806 |
| Camk2b | -692 |
| Grin2c | 2617 |
| Grin2d | 5159 |
| GeneID | Gene Rank |
|---|---|
| Grin2a | -7764 |
| Lrrc7 | -7139 |
| Dlg4 | -6875 |
| Grin2b | -6798 |
| Actn2 | -6716 |
| Dlg1 | -6542 |
| Dlg3 | -6389 |
| Ppm1f | -6175 |
| Calm1 | -6088 |
| Camk4 | -6010 |
| Camk1 | -5655 |
| Dlg2 | -4965 |
| Camk2a | -4371 |
| Grin1 | -3658 |
| Nefl | -1421 |
| Ppm1e | -1341 |
| Camk2g | -806 |
| Camk2b | -692 |
| Grin2c | 2617 |
| Grin2d | 5159 |
| Camk2d | 6087 |
REGULATION OF MECP2 EXPRESSION AND ACTIVITY
| 810 | |
|---|---|
| set | REGULATION OF MECP2 EXPRESSION AND ACTIVITY |
| setSize | 30 |
| pANOVA | 0.000954 |
| s.dist | -0.349 |
| p.adjustANOVA | 0.0305 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Creb1 | -8839 |
| Ago3 | -8593 |
| Tnrc6b | -7781 |
| Ago2 | -7704 |
| Gps2 | -7695 |
| Ago4 | -6947 |
| Tbl1x | -6921 |
| Calm1 | -6088 |
| Foxg1 | -6076 |
| Camk4 | -6010 |
| Tbl1xr1 | -5356 |
| Htt | -5284 |
| Ncor1 | -5255 |
| Mov10 | -5114 |
| Mecp2 | -5028 |
| Hipk2 | -4466 |
| Camk2a | -4371 |
| Sin3a | -4327 |
| Ncor2 | -3759 |
| Hdac2 | -3617 |
| GeneID | Gene Rank |
|---|---|
| Creb1 | -8839 |
| Ago3 | -8593 |
| Tnrc6b | -7781 |
| Ago2 | -7704 |
| Gps2 | -7695 |
| Ago4 | -6947 |
| Tbl1x | -6921 |
| Calm1 | -6088 |
| Foxg1 | -6076 |
| Camk4 | -6010 |
| Tbl1xr1 | -5356 |
| Htt | -5284 |
| Ncor1 | -5255 |
| Mov10 | -5114 |
| Mecp2 | -5028 |
| Hipk2 | -4466 |
| Camk2a | -4371 |
| Sin3a | -4327 |
| Ncor2 | -3759 |
| Hdac2 | -3617 |
| Hdac3 | -2903 |
| Camk2g | -806 |
| Camk2b | -692 |
| Tnrc6a | 21 |
| Hdac1 | 876 |
| Lbr | 1730 |
| Ago1 | 2169 |
| Tnrc6c | 2469 |
| Prkaca | 2759 |
| Camk2d | 6087 |
ANTIMICROBIAL PEPTIDES
| 59 | |
|---|---|
| set | ANTIMICROBIAL PEPTIDES |
| setSize | 15 |
| pANOVA | 0.0219 |
| s.dist | 0.342 |
| p.adjustANOVA | 0.184 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| S100a9 | 7607 |
| Lyz2 | 7349 |
| Defb1 | 6823 |
| Chga | 5832 |
| Prtn3 | 4378 |
| Pglyrp1 | 4053 |
| Atox1 | 3867 |
| Clu | 2475 |
| Slc11a1 | 2123 |
| Pdzd11 | 1614 |
| Tlr2 | -736 |
| Defb42 | -793 |
| Tlr1 | -996 |
| Lcn2 | -4617 |
| Atp7a | -5080 |
| GeneID | Gene Rank |
|---|---|
| S100a9 | 7607 |
| Lyz2 | 7349 |
| Defb1 | 6823 |
| Chga | 5832 |
| Prtn3 | 4378 |
| Pglyrp1 | 4053 |
| Atox1 | 3867 |
| Clu | 2475 |
| Slc11a1 | 2123 |
| Pdzd11 | 1614 |
| Tlr2 | -736 |
| Defb42 | -793 |
| Tlr1 | -996 |
| Lcn2 | -4617 |
| Atp7a | -5080 |
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS
| 495 | |
|---|---|
| set | IONOTROPIC ACTIVITY OF KAINATE RECEPTORS |
| setSize | 10 |
| pANOVA | 0.0619 |
| s.dist | -0.341 |
| p.adjustANOVA | 0.298 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Grik2 | -7255 |
| Grik5 | -7254 |
| Dlg4 | -6875 |
| Dlg1 | -6542 |
| Dlg3 | -6389 |
| Calm1 | -6088 |
| Grik3 | -2135 |
| Ncald | -224 |
| Grik4 | 90 |
| Grik1 | 7440 |
| GeneID | Gene Rank |
|---|---|
| Grik2 | -7255 |
| Grik5 | -7254 |
| Dlg4 | -6875 |
| Dlg1 | -6542 |
| Dlg3 | -6389 |
| Calm1 | -6088 |
| Grik3 | -2135 |
| Ncald | -224 |
| Grik4 | 90 |
| Grik1 | 7440 |
PLASMA LIPOPROTEIN ASSEMBLY
| 712 | |
|---|---|
| set | PLASMA LIPOPROTEIN ASSEMBLY |
| setSize | 11 |
| pANOVA | 0.0517 |
| s.dist | 0.339 |
| p.adjustANOVA | 0.271 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| A2m | 7807 |
| Abca1 | 7357 |
| Apoe | 6190 |
| Mttp | 4599 |
| Sar1b | 3196 |
| Prkaca | 2759 |
| Apoc1 | 2383 |
| Zdhhc8 | 1772 |
| P4hb | 406 |
| Prkacb | -5917 |
| Bmp1 | -5954 |
| GeneID | Gene Rank |
|---|---|
| A2m | 7807 |
| Abca1 | 7357 |
| Apoe | 6190 |
| Mttp | 4599 |
| Sar1b | 3196 |
| Prkaca | 2759 |
| Apoc1 | 2383 |
| Zdhhc8 | 1772 |
| P4hb | 406 |
| Prkacb | -5917 |
| Bmp1 | -5954 |
GP1B IX V ACTIVATION SIGNALLING
| 398 | |
|---|---|
| set | GP1B IX V ACTIVATION SIGNALLING |
| setSize | 10 |
| pANOVA | 0.0652 |
| s.dist | 0.337 |
| p.adjustANOVA | 0.307 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Col1a2 | 7774 |
| Col1a1 | 7347 |
| Gp5 | 6795 |
| Vwf | 5862 |
| Gp1ba | 3023 |
| Pik3r1 | 1171 |
| Raf1 | -1126 |
| Ywhaz | -1970 |
| Src | -2599 |
| Flna | -4088 |
| GeneID | Gene Rank |
|---|---|
| Col1a2 | 7774 |
| Col1a1 | 7347 |
| Gp5 | 6795 |
| Vwf | 5862 |
| Gp1ba | 3023 |
| Pik3r1 | 1171 |
| Raf1 | -1126 |
| Ywhaz | -1970 |
| Src | -2599 |
| Flna | -4088 |
NUCLEOBASE CATABOLISM
| 657 | |
|---|---|
| set | NUCLEOBASE CATABOLISM |
| setSize | 31 |
| pANOVA | 0.00119 |
| s.dist | 0.336 |
| p.adjustANOVA | 0.0339 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Xdh | 7727 |
| Nudt1 | 7672 |
| Nudt16 | 7477 |
| Nudt9 | 7452 |
| Entpd3 | 7433 |
| Nudt15 | 7324 |
| Nt5c | 7081 |
| Dnph1 | 6968 |
| Entpd4 | 5871 |
| Nt5e | 5797 |
| Nt5c2 | 5669 |
| Entpd5 | 5520 |
| Nt5c3 | 4708 |
| Nt5m | 3920 |
| Upb1 | 3129 |
| Tymp | 3045 |
| Entpd2 | 2914 |
| Itpa | 1733 |
| Pnp2 | 1058 |
| Nt5c1a | 1052 |
| GeneID | Gene Rank |
|---|---|
| Xdh | 7727 |
| Nudt1 | 7672 |
| Nudt16 | 7477 |
| Nudt9 | 7452 |
| Entpd3 | 7433 |
| Nudt15 | 7324 |
| Nt5c | 7081 |
| Dnph1 | 6968 |
| Entpd4 | 5871 |
| Nt5e | 5797 |
| Nt5c2 | 5669 |
| Entpd5 | 5520 |
| Nt5c3 | 4708 |
| Nt5m | 3920 |
| Upb1 | 3129 |
| Tymp | 3045 |
| Entpd2 | 2914 |
| Itpa | 1733 |
| Pnp2 | 1058 |
| Nt5c1a | 1052 |
| Entpd6 | 798 |
| Upp2 | 219 |
| Samhd1 | -105 |
| Nudt18 | -161 |
| Dpyd | -2174 |
| Gda | -2811 |
| Nudt5 | -4317 |
| Entpd7 | -4725 |
| Entpd1 | -5713 |
| Upp1 | -7532 |
| Adprm | -8429 |
INSULIN PROCESSING
| 454 | |
|---|---|
| set | INSULIN PROCESSING |
| setSize | 24 |
| pANOVA | 0.00439 |
| s.dist | -0.336 |
| p.adjustANOVA | 0.0746 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Ero1b | -8070 |
| Stx1a | -8025 |
| Ero1a | -7886 |
| Kif5c | -7064 |
| Pcsk1 | -6590 |
| Slc30a5 | -6551 |
| Exoc3 | -5285 |
| Exoc1 | -4979 |
| Vamp2 | -4832 |
| Kif5b | -4707 |
| Myrip | -4625 |
| Exoc8 | -4238 |
| Exoc6 | -3883 |
| Exoc5 | -3856 |
| Myo5a | -3605 |
| Kif5a | -2914 |
| Pcsk2 | -2908 |
| Exoc4 | -2234 |
| Exoc7 | -1402 |
| Slc30a7 | -717 |
| GeneID | Gene Rank |
|---|---|
| Ero1b | -8070 |
| Stx1a | -8025 |
| Ero1a | -7886 |
| Kif5c | -7064 |
| Pcsk1 | -6590 |
| Slc30a5 | -6551 |
| Exoc3 | -5285 |
| Exoc1 | -4979 |
| Vamp2 | -4832 |
| Kif5b | -4707 |
| Myrip | -4625 |
| Exoc8 | -4238 |
| Exoc6 | -3883 |
| Exoc5 | -3856 |
| Myo5a | -3605 |
| Kif5a | -2914 |
| Pcsk2 | -2908 |
| Exoc4 | -2234 |
| Exoc7 | -1402 |
| Slc30a7 | -717 |
| Rab27a | -249 |
| Slc30a6 | 2060 |
| Cpe | 2147 |
| Exoc2 | 6926 |
SIGNALING BY KIT IN DISEASE
| 964 | |
|---|---|
| set | SIGNALING BY KIT IN DISEASE |
| setSize | 20 |
| pANOVA | 0.00973 |
| s.dist | -0.334 |
| p.adjustANOVA | 0.116 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Nras | -8330 |
| Stat1 | -8227 |
| Pik3ca | -8013 |
| Jak2 | -7896 |
| Lyn | -7599 |
| Kit | -6898 |
| Kras | -5974 |
| Yes1 | -5755 |
| Sos1 | -5137 |
| Pik3r3 | -4681 |
| Lck | -3363 |
| Stat5b | -2741 |
| Src | -2599 |
| Pik3r2 | -2288 |
| Stat3 | 82 |
| Grb2 | 373 |
| Hras | 593 |
| Pik3r1 | 1171 |
| Fyn | 2255 |
| Stat5a | 5779 |
| GeneID | Gene Rank |
|---|---|
| Nras | -8330 |
| Stat1 | -8227 |
| Pik3ca | -8013 |
| Jak2 | -7896 |
| Lyn | -7599 |
| Kit | -6898 |
| Kras | -5974 |
| Yes1 | -5755 |
| Sos1 | -5137 |
| Pik3r3 | -4681 |
| Lck | -3363 |
| Stat5b | -2741 |
| Src | -2599 |
| Pik3r2 | -2288 |
| Stat3 | 82 |
| Grb2 | 373 |
| Hras | 593 |
| Pik3r1 | 1171 |
| Fyn | 2255 |
| Stat5a | 5779 |
PLATELET ADHESION TO EXPOSED COLLAGEN
| 717 | |
|---|---|
| set | PLATELET ADHESION TO EXPOSED COLLAGEN |
| setSize | 11 |
| pANOVA | 0.0566 |
| s.dist | 0.332 |
| p.adjustANOVA | 0.285 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Col1a2 | 7774 |
| Col1a1 | 7347 |
| Gp5 | 6795 |
| Vwf | 5862 |
| Itgb1 | 4544 |
| Gp1ba | 3023 |
| Fyn | 2255 |
| Fcer1g | 486 |
| Itga1 | 334 |
| Itga10 | -6866 |
| Lyn | -7599 |
| GeneID | Gene Rank |
|---|---|
| Col1a2 | 7774 |
| Col1a1 | 7347 |
| Gp5 | 6795 |
| Vwf | 5862 |
| Itgb1 | 4544 |
| Gp1ba | 3023 |
| Fyn | 2255 |
| Fcer1g | 486 |
| Itga1 | 334 |
| Itga10 | -6866 |
| Lyn | -7599 |
ASPARTATE AND ASPARAGINE METABOLISM
| 73 | |
|---|---|
| set | ASPARTATE AND ASPARAGINE METABOLISM |
| setSize | 11 |
| pANOVA | 0.0568 |
| s.dist | 0.332 |
| p.adjustANOVA | 0.285 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Slc25a13 | 7827 |
| Aspg | 6652 |
| Folh1 | 5836 |
| Gadl1 | 5172 |
| Slc25a12 | 4582 |
| Naalad2 | 3003 |
| Aspa | 1175 |
| Got2 | 447 |
| Got1 | 260 |
| Nat8l | -4408 |
| Asns | -6612 |
| GeneID | Gene Rank |
|---|---|
| Slc25a13 | 7827 |
| Aspg | 6652 |
| Folh1 | 5836 |
| Gadl1 | 5172 |
| Slc25a12 | 4582 |
| Naalad2 | 3003 |
| Aspa | 1175 |
| Got2 | 447 |
| Got1 | 260 |
| Nat8l | -4408 |
| Asns | -6612 |
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS
| 402 | |
|---|---|
| set | GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS |
| setSize | 12 |
| pANOVA | 0.0472 |
| s.dist | -0.331 |
| p.adjustANOVA | 0.264 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Tln1 | -8767 |
| Rap1a | -8221 |
| Ptk2 | -7979 |
| Itga2b | -7092 |
| Itgb3 | -5396 |
| Rap1b | -5343 |
| Sos1 | -5137 |
| Apbb1ip | -3478 |
| Src | -2599 |
| Grb2 | 373 |
| Vwf | 5862 |
| Fn1 | 6528 |
| GeneID | Gene Rank |
|---|---|
| Tln1 | -8767 |
| Rap1a | -8221 |
| Ptk2 | -7979 |
| Itga2b | -7092 |
| Itgb3 | -5396 |
| Rap1b | -5343 |
| Sos1 | -5137 |
| Apbb1ip | -3478 |
| Src | -2599 |
| Grb2 | 373 |
| Vwf | 5862 |
| Fn1 | 6528 |
REGULATION OF IFNA SIGNALING
| 802 | |
|---|---|
| set | REGULATION OF IFNA SIGNALING |
| setSize | 12 |
| pANOVA | 0.0485 |
| s.dist | -0.329 |
| p.adjustANOVA | 0.264 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Stat2 | -8570 |
| Ifnar1 | -8447 |
| Stat1 | -8227 |
| Usp18 | -7729 |
| Tyk2 | -5608 |
| Ptpn6 | -4543 |
| Ptpn1 | -4036 |
| Socs3 | -2442 |
| Jak1 | 249 |
| Ifnar2 | 2127 |
| Ptpn11 | 3062 |
| Socs1 | 3109 |
| GeneID | Gene Rank |
|---|---|
| Stat2 | -8570 |
| Ifnar1 | -8447 |
| Stat1 | -8227 |
| Usp18 | -7729 |
| Tyk2 | -5608 |
| Ptpn6 | -4543 |
| Ptpn1 | -4036 |
| Socs3 | -2442 |
| Jak1 | 249 |
| Ifnar2 | 2127 |
| Ptpn11 | 3062 |
| Socs1 | 3109 |
VEGFR2 MEDIATED CELL PROLIFERATION
| 1159 | |
|---|---|
| set | VEGFR2 MEDIATED CELL PROLIFERATION |
| setSize | 19 |
| pANOVA | 0.0132 |
| s.dist | -0.328 |
| p.adjustANOVA | 0.143 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Kdr | -8948 |
| Prkcb | -8533 |
| Nras | -8330 |
| Prkcz | -7749 |
| Itpr1 | -6977 |
| Rasa1 | -6962 |
| Calm1 | -6088 |
| Kras | -5974 |
| Pdpk1 | -5921 |
| Prkca | -5046 |
| Itpr2 | -3995 |
| Plcg1 | -3767 |
| Src | -2599 |
| Vegfa | -2547 |
| Itpr3 | -1106 |
| Hras | 593 |
| Ahcyl1 | 4360 |
| Prkcd | 6929 |
| Sphk1 | 7755 |
| GeneID | Gene Rank |
|---|---|
| Kdr | -8948 |
| Prkcb | -8533 |
| Nras | -8330 |
| Prkcz | -7749 |
| Itpr1 | -6977 |
| Rasa1 | -6962 |
| Calm1 | -6088 |
| Kras | -5974 |
| Pdpk1 | -5921 |
| Prkca | -5046 |
| Itpr2 | -3995 |
| Plcg1 | -3767 |
| Src | -2599 |
| Vegfa | -2547 |
| Itpr3 | -1106 |
| Hras | 593 |
| Ahcyl1 | 4360 |
| Prkcd | 6929 |
| Sphk1 | 7755 |
CD209 DC SIGN SIGNALING
| 122 | |
|---|---|
| set | CD209 DC SIGN SIGNALING |
| setSize | 18 |
| pANOVA | 0.016 |
| s.dist | -0.328 |
| p.adjustANOVA | 0.158 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Nras | -8330 |
| Icam2 | -7917 |
| Lyn | -7599 |
| Crebbp | -6906 |
| Pak1 | -6645 |
| Kras | -5974 |
| Prkacb | -5917 |
| Rela | -4265 |
| Relb | -3693 |
| Ep300 | -3538 |
| Pak3 | -3417 |
| Nfkb1 | -2356 |
| Pak2 | -1312 |
| Raf1 | -1126 |
| Hras | 593 |
| Rps6ka5 | 1978 |
| Fyn | 2255 |
| Prkaca | 2759 |
| GeneID | Gene Rank |
|---|---|
| Nras | -8330 |
| Icam2 | -7917 |
| Lyn | -7599 |
| Crebbp | -6906 |
| Pak1 | -6645 |
| Kras | -5974 |
| Prkacb | -5917 |
| Rela | -4265 |
| Relb | -3693 |
| Ep300 | -3538 |
| Pak3 | -3417 |
| Nfkb1 | -2356 |
| Pak2 | -1312 |
| Raf1 | -1126 |
| Hras | 593 |
| Rps6ka5 | 1978 |
| Fyn | 2255 |
| Prkaca | 2759 |
BRANCHED CHAIN AMINO ACID CATABOLISM
| 104 | |
|---|---|
| set | BRANCHED CHAIN AMINO ACID CATABOLISM |
| setSize | 21 |
| pANOVA | 0.00975 |
| s.dist | 0.326 |
| p.adjustANOVA | 0.116 |
Top enriched genes
| GeneID | Gene Rank |
|---|---|
| Hsd17b10 | 7608 |
| Acat1 | 7524 |
| Mccc2 | 7514 |
| Echs1 | 7001 |
| Bckdha | 6588 |
| Bcat1 | 4687 |
| Dbt | 4003 |
| Aldh6a1 | 3709 |
| Acad8 | 3573 |
| Slc25a44 | 3392 |
| Ivd | 3201 |
| Mccc1 | 1693 |
| Dld | 1533 |
| Bckdhb | 1433 |
| Bckdk | 1357 |
| Auh | -374 |
| Hibadh | -714 |
| Acadsb | -1149 |
| Hibch | -1684 |
| Bcat2 | -7816 |
| GeneID | Gene Rank |
|---|---|
| Hsd17b10 | 7608 |
| Acat1 | 7524 |
| Mccc2 | 7514 |
| Echs1 | 7001 |
| Bckdha | 6588 |
| Bcat1 | 4687 |
| Dbt | 4003 |
| Aldh6a1 | 3709 |
| Acad8 | 3573 |
| Slc25a44 | 3392 |
| Ivd | 3201 |
| Mccc1 | 1693 |
| Dld | 1533 |
| Bckdhb | 1433 |
| Bckdk | 1357 |
| Auh | -374 |
| Hibadh | -714 |
| Acadsb | -1149 |
| Hibch | -1684 |
| Bcat2 | -7816 |
| Ppm1k | -8467 |
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.2.1 (2022-06-23)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.1 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/openblas-pthread/libblas.so.3
## LAPACK: /usr/lib/x86_64-linux-gnu/openblas-pthread/libopenblasp-r0.3.20.so
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## attached base packages:
## [1] stats4 stats graphics grDevices utils datasets methods
## [8] base
##
## other attached packages:
## [1] pkgload_1.3.0 GGally_2.1.2
## [3] gtools_3.9.3 echarts4r_0.4.4
## [5] beeswarm_0.4.0 vioplot_0.3.7
## [7] sm_2.2-5.7.1 kableExtra_1.3.4
## [9] topconfects_1.12.0 limma_3.52.4
## [11] eulerr_6.1.1 mitch_1.8.0
## [13] MASS_7.3-58.1 fgsea_1.22.0
## [15] gplots_3.1.3 DESeq2_1.36.0
## [17] SummarizedExperiment_1.26.1 Biobase_2.56.0
## [19] MatrixGenerics_1.8.1 matrixStats_0.62.0
## [21] GenomicRanges_1.48.0 GenomeInfoDb_1.32.4
## [23] IRanges_2.30.1 S4Vectors_0.34.0
## [25] BiocGenerics_0.42.0 reshape2_1.4.4
## [27] forcats_0.5.2 stringr_1.4.1
## [29] dplyr_1.0.10 purrr_0.3.5
## [31] readr_2.1.3 tidyr_1.2.1
## [33] tibble_3.1.8 ggplot2_3.3.6
## [35] tidyverse_1.3.2 zoo_1.8-11
##
## loaded via a namespace (and not attached):
## [1] googledrive_2.0.0 colorspace_2.0-3 ellipsis_0.3.2
## [4] XVector_0.36.0 fs_1.5.2 rstudioapi_0.14
## [7] bit64_4.0.5 AnnotationDbi_1.58.0 fansi_1.0.3
## [10] lubridate_1.8.0 xml2_1.3.3 codetools_0.2-18
## [13] splines_4.2.1 cachem_1.0.6 knitr_1.40
## [16] geneplotter_1.74.0 jsonlite_1.8.2 broom_1.0.1
## [19] annotate_1.74.0 dbplyr_2.2.1 png_0.1-7
## [22] shiny_1.7.2 compiler_4.2.1 httr_1.4.4
## [25] backports_1.4.1 assertthat_0.2.1 Matrix_1.5-1
## [28] fastmap_1.1.0 gargle_1.2.1 cli_3.4.1
## [31] later_1.3.0 htmltools_0.5.3 tools_4.2.1
## [34] gtable_0.3.1 glue_1.6.2 GenomeInfoDbData_1.2.8
## [37] fastmatch_1.1-3 Rcpp_1.0.9 jquerylib_0.1.4
## [40] cellranger_1.1.0 vctrs_0.4.2 Biostrings_2.64.1
## [43] svglite_2.1.0 xfun_0.33 rvest_1.0.3
## [46] mime_0.12 lifecycle_1.0.3 XML_3.99-0.11
## [49] googlesheets4_1.0.1 zlibbioc_1.42.0 scales_1.2.1
## [52] hms_1.1.2 promises_1.2.0.1 parallel_4.2.1
## [55] RColorBrewer_1.1-3 yaml_2.3.5 memoise_2.0.1
## [58] gridExtra_2.3 sass_0.4.2 reshape_0.8.9
## [61] stringi_1.7.8 RSQLite_2.2.18 highr_0.9
## [64] genefilter_1.78.0 caTools_1.18.2 BiocParallel_1.30.3
## [67] systemfonts_1.0.4 rlang_1.0.6 pkgconfig_2.0.3
## [70] bitops_1.0-7 evaluate_0.17 lattice_0.20-45
## [73] htmlwidgets_1.5.4 bit_4.0.4 tidyselect_1.2.0
## [76] plyr_1.8.7 magrittr_2.0.3 R6_2.5.1
## [79] generics_0.1.3 DelayedArray_0.22.0 DBI_1.1.3
## [82] pillar_1.8.1 haven_2.5.1 withr_2.5.0
## [85] survival_3.4-0 KEGGREST_1.36.3 RCurl_1.98-1.9
## [88] modelr_0.1.9 crayon_1.5.2 KernSmooth_2.23-20
## [91] utf8_1.2.2 rmarkdown_2.17 tzdb_0.3.0
## [94] locfit_1.5-9.6 grid_4.2.1 readxl_1.4.1
## [97] data.table_1.14.2 blob_1.2.3 webshot_0.5.4
## [100] reprex_2.0.2 digest_0.6.29 xtable_1.8-4
## [103] httpuv_1.6.6 munsell_0.5.0 viridisLite_0.4.1
## [106] bslib_0.4.0
END of report